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ABSTRACT
Bombesin is a tetradecapeptide first isolated from frog
skin.

This peptide has potent effects on core body

temperature of rats when administered centrally.
Bombesin-induced hypothermia at normal ambient
temperatures appears to be dependent upon some
pre-existent condition which may be related to nutritional
status.

Four experiments were conducted to examine if the

pre-existing condition for bombesin-induced hypothermia at
normal ambient temperatures is primarily related to
modulation of sympathetic nervous system activation.
Experiment I demonstrated that central bombesin resulted
in hypothermia in rats tested at normal ambient
temperatures under conditions of ad-libitum access to food
only when injected peripherally with the ganglionic
blocker chlorisondamine.

Experiment II demonstrated that

bombesin-induced hypothermia in ad-libitum fed rats
treated with chlorisondamine is prevented by peripheral
injection wit h the P3-adrenergic receptor agonist,

CL-316,243.

Experiment III demonstrates that

bombesin-induced hypothermia seen in acutely food-deprived
rats is prevented by peripheral injection of CL-316,243.
Experiment IV establishes that bombesin-induced
hypothermia seen in acutely food-deprived rats is not
dependent upon adrenal catecholamines and that peripheral

ix

corticosterone injection may promote hypothermia, possibly
by suppression of corticotrophin-releasing hormone.

The

results are discussed in relation to sympathetic nervous
system modulation and nutritional status.

x

INTRODUCTION
Isolation and Characterization of Bombesin
A number of peptides that were first isolated in
nonneural tissue have also been found in the central
nervous system (Krieger, 1983).

Many of these

neuropeptides appear to function as neurotransmitters
and/or neuromodulators (Krieger, 1983).

A

neurotransmitter is a substance, that when liberated from
presynaptic terminals, will interact with receptors on a
postsynaptic membrane of an adjacent cell (Krieger, 1983) .
A neuromodulator represents a substance with nonclassical
transmitter actions.

It affects the actions of

neurotransmitters by modifying their prototypical actions,
for example, by blocking the release of specific
transmitters or altering the synthesis and degradation of
the transmitters (Krieger, 1983).
In 1970, Erspamer and coworkers isolated and
characterized the tetradecapeptide bombesin from the skin
of the European discoglossid frog Bowbina bombina
(Erspamer, Erpamer, & Inselvini, 1970).

This peptide is

structurally similar to the peptide ranatensin (Geller,
Govier, Pisano, Tanimura, & Van Clineschmidt, 1970; Van
Clineschmidt, Geller, Govier, Pisano, & Tanimura, 1971).
Both of these peptides have a general contractile type of
activity on the majority of extravascular smooth muscle in
mammals (Erspamer, Erspamer, Inselvini, & Negri, 1972).
1
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In 1971 a methodology for the synthesis of bombesin in the
laboratory was reported (Bernardi, de Castiglione,
Goffredo, & Angelucci, 1971).

As research into isolation

of bioactive peptides continued several other peptides
were discovered that shared similar structure and
biological activity with bombesin.

In 1970, the isolation

of the peptide alytesin from the skin of European
discoglossid frog Alytes obstetricans was reported
(Anastasi, Erspamer, & Bucci, 1971) .

The amino acid

sequence of bombesin and alytesin differ in only two
positions, the second and sixth from the N-terminus
(Anastasi, Erspamer, & Bucci, 1971).

Additionally, the

peptide neuromedin-B shares biological activity with
bombesin (Minamino, Kangawa, & Matsuo, 1983) as does
neuromedin-C (Minamino, Kangawa, & Matsuo, 1984) .

These

peptides, which were discovered to have similar amino acid
sequence and share biological activity with bombesin,
became known as bombesin-like peptides.

The amino acid

sequence of several of these bombesin-like peptides is
depicted in Figure 1.
Research into the physiological effects of bombesin
show that synthetic analogs of bombesin which have
modifications of sequence near the N-terminal produce a
reduction in receptor binding (Moody, Crawley, & Jensen,
1982).

Additional data demonstrated that the C-terminal

of the bombesin peptide chain was required for high

Bombesin
GRP (14-27)
Litorin
Ranatensin

pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NHj
Met-Tyr-Pro-Arg-Gly-Asp-His-Trp-Ala-Val-Gly-His-Leu-Met-NHj
pGlu-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NHj
pGlu-Val-Pro-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NHj

Neuromedin-B

Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NHj

Neuromedin-C

Gly-Asn-His-Tqj-Ala-Val-Gly-His-Leu-Met-NHj

Figure 1.
peptides.

Amino acid sequence of selected bombesin-like
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affinity binding and potent biological activity (Moody,
Crawley, & Jensen, 1982).

Other researchers have shown

that bombesin-like peptides not containing tryptophan
appear to have actions specific to the mammalian urinary
bladder (Erspamer, 1988).

The inclusion of tryptophan in

the sequence of bombesin-like peptides is mandatory for
the production of its effects on smooth muscle and the
gastrointestinal tract (Erspamer, 1988).

It was further

established that in the bombesin subfamily of peptides, a
minimum amino acid chain length of 9 is required for the
full spectrum of bombesin-like activity on all type of
smooth muscle preparations (Broccardo, Falconieri
Erspamer, Melchiorri, Negri, & de Castiglione, 1975).

The

evidence that bombesin-like peptides with different amino
acid structures act on separate tissues of the body
suggests the existence of multiple bombesin receptor
subtypes distributed in the periphery (Erspamer, 1988).
Gel chromatographic evidence indicates that true
amphibian bombesin is not present in mammalian tissues
(Walsh, Wong, & Dockray, 1979).

In 1979 a mammalian

counter part to bombesin was isolated from porcine gastric
tissue (McDonald et al., 1979).

This 27-amino acid

peptide has an amino acid sequence similar to bombesin,
and when administered peripherally, causes the release of
gastrin.

Thus this new peptide isolated in mammalian

tissue became known as gastrin-releasing peptide (GRP).
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The carboxyl-terminal sequences of bombesin and GRP are
identical in 9 of 10 amino acid residues (Reeve, Cuttitta,
Vigna, Shively & Walsh, 1988).

Gastrin releasing peptide

is considered to be a mammalian analog of amphibian
bombesin (Furness, Miller & Costa, 1988).

While bombesin

exerts biological activities which are similar to those of
GRP, and the two are considered analogs, bombesin does not
act as a gastrin releasing peptide in amphibians (van
Wimersma Greidanus et a l., 1984).

It has been proposed

that amphibian bombesin isolated from the skin of frogs of
the Disscoglossid family does not function as a
neurotransmitter or neuromodulator in amphibians and that
its structural similarity with GRP is secondary to
convergent evolution (van Wimersma Greidanus et a l .,
1984).

DISTRIBUTION OF BOMBESIN-LIKE PEPTIDES
Peripheral Distribution
Bombesin-like immunoreactivity (BLI) in mammalian
tissue is found in the greatest concentrations in the
stomach (Furness, Miller & Costa, 1988).

Significant

concentrations of BLI are also found throughout the
gastrointestinal tract and minor concentrations are found
in the heart and lung (Brown, Allen, Villarreal, Rivier, &
Vale, 1978).

No detectable concentrations have been found

in the adrenals, liver, kidney, pancreas, spleen, or
skeletal muscles (Brown, Allen, Villarreal, Rivier, &
Vale, 1978).

The BLI found in the stomach is localized

within nerve cell bodies in the myenteric ganglia, muscle
coats, and antral and nonantral regions of the gastric
mucosa (Dockray, Vaillant, & Walsh, 1979; Tache, Brown, &
Collu, 1979).

There were few BLI ganglia found within the

submucosa (Christensen & Rick, 1989).

In the small

intestine, immunoreactive cell bodies are encountered in
the myenteric plexus, submucosal plexus, and myenteric
ganglia (Dockray, Vaillant, & Walsh, 1979).
Immunoreactive ganglia are rare or absent within the
mucosa of the small intestine (Furness, Miller & Costa,
1988).

Within the large intestine of the rat and

mouse, BLI fibers appear in the lamina propria of the
mucosa (Moghimzadeh, Ekman, Hakanson, Yanaihara, &
Sundler, 1983).
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Central Distribution
High concentrations of BLI are found in the
hypothalamus and pons/medulla areas (Panula, Yang, &
Costa, 1982).

Additionally, bombesin-like immunoreactive

cell bodies are found in the trigeminal complex and nuclei
(Panula, Yang, & Costa, 1982), an area involved in
regulation of autonomic functions.

Bombesin-like

immunoreactive cell bodies have also been found in the
preoptic area of the hypothalamus, the ventral and medial
parvocellular part of the paraventricular nucleus, and the
suprachiasmatic nucleus (Pannula, Nieminen, Falkenberg &
Auvinen, 1988) .
In the pons/medulla regions, bombesin-like activity
has been detected in the laterodorsal tegmental nucleus,
the nucleus of the solitary tract, and the parabrachial
nucleus (Pannula, Nieminen, Falkenberg & Auvinen, 1988).
No detectable concentrations of BLI are found in the
regions of the pituitary, pineal, or cerebellum (Brown,
Allen, Villarreal, Rivier, & Vale, 1978; Walsh, Wong, &
Dockray, 1979) .
Using autoradiography, high densities of
bombesin-like receptors have been identified in the
anterior olfactory nucleus accumbens, and olfactory
tubercule (Moody, Getz, O'Donohue, & Rosenstein, 1988) .
This method also revealed high densities within the
central medial and paraventricular nuclei of the thalamus,

the paraventricular nuclei of the hypothalamus, the
central and medial amygdaloid nuclei, and the dentate
gyrus (Moody, Getz, O'Donohue, & Rosenstein, 1988; Wolf &
Moody, 1985) .

High densities of bombesin-like receptors

are also found in the hippocampus (Pert, Moody, Pert,
Dewald, & Rivier, 1980).
Moderate densities of receptors have been found in
the internal granule layer of the olfactory bulb, frontal
cortex of the forebrain, basal caudate putamen, rhinal
cortex, rhinal neocortex, septohippicampal nucleus, bed
nucleus of the stria terminalis, anterior hypothalamus,
and medial preoptic nucleus (Moody, Getz, O'Donohue, &
Rosenstein, 1988).

The lowest densities were found in the

cerebellum, medial forebrain bundle, lateral preoptic
nucleus, and ventral pallidum areas of the anterior rat
brain (Moody, Getz, O'Donohue, & Rosenstein, 1988).

The

lateral hypothalamus, and the ventromedial and dorsomedial
hypothalamic nuclei also demonstrate low binding densities
(Moody, Getz, O'Donohue, & Rosenstein, 1988).

Within the

midbrain, the central grey and reticular substantia nigra,
superficial grey layer of the colliculus, and dorsal raphe
nuclei have low densities of bombesin-like activity
(Moody, Getz, O'Donohue, & Rosenstein, 1988).
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Receptor Subtypes
While GRP, neuromedin-B, and neuromedin-C belong to
the same family of bombesin-like peptides, they display
significant differences in sequence homology.
Neuromedin-C and GRP share the carboxyl-terminal
heptapeptide sequence, which is the biologically active
segment of these peptides, with amphibian bombesin
(Minamino, Kangawa, & Matsuo, 1984; Minamino, Kangawa, &
Matsuo, 1983).

In contrast, neuromedin-B appears to share

a much closer sequence homology with the amphibian
oligopeptide litorin (Minamino, Kangawa, & Matsuo, 1984;
Minamino, Kangawa, & Matsuo, 1983).

These findings have

been suggested to constitute a basis for the possible
existence of multiple bombesin receptor types (Von
Schrenck et a l ., 1989).
Using autoradiography, it has been shown that two
different receptor sites for bombesin-like peptides exists
in the periphery (Von Schrenck et al., 1989).
Radio-labeled bombesin was found to bind with receptors in
both the esophagus and pancreas while radio-labeled
neuromedin-B bound only with the epithehial cells of the
esophagus (Von Schrenck et al., 1989).

In each of these

tissue types, binding of the radio-labled peptides was
saturable, dependent on pH, time, and temperature, as well
as being reversible and specific (Von Schrenck et a l .,
1989).

In the esophagus the relative potencies for
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inhibition of binding of both tracers illustrated that
neuromedin-B bound more strongly than bombesin and GRP
(Von Schrenck et al ., 1989).

In the pancreatic tissue

assays, bombesin and GRP bound more potently than
neuromedin-B (Von Schrenck et al., 1989).

Computer

analysis of the binding sites revealed that a single
binding site existed in assays of each tissue, and that
differences in binding between tissues and peptide could
only be explained by way of at least two subtypes of
bombesin receptors in the periphery (Von Schrenck et a l .,
1989).

There is a heterogeneity of bombesin receptor

sites in the rat central nervous system.

The rat cerebral

cortex appears to contain many more neuromedin-B receptors
than bombesin/GRP receptors (Ladenheim, Jensen, Mantey,
McHugh, & Moran, 1990).

In the nucleus accumbens,

neuromedin-B was less effective at inhibiting binding of
radio-labeled bombesin, suggesting that this area is more
sensitive to binding by bombesin (Ladenheim, Jensen,
Mantey, McHugh, & Moran, 1990).

In assays of the nucleus

of the solitary tract, it appears that neuromedin-B binds
with much greater affinity to receptors than does bombesin
(Ladenheim, Jensen, Mantey, McHugh, & Moran, 1990).
Using an in vitro autoradiographic methodology,
Ladenheim and coworkers have isolated two distinct
bombesin receptor subtypes in the rat central nervous
system which correspond to bombesin/GRP and neuromedin-B
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(Ladenheim, Jensen, Mantey, & Moran, 1992) .

In examining

the differentiation of binding patterns, it was discovered
that three general distributions of bombesin-like peptide
binding exist.

One distinct pattern of binding is

referred to as bombesin/GRP-preffering, and is comprised
of the supraoptic nucleus, paraventricular nucleus, the
arcuate nucleus, and the outer rim of the hippocampal
oriens layer (Ladenheim, Jensen, Mantey, & Moran, 1992).
A second pattern, which has been designated as
neuromedin-B preferring includes the thalamus, dentate
gyrus, and ventromedial hypothalamus (Ladenheim, Jensen,
Mantey, & Moran, 1992) .

A third pattern of binding was

discovered in the spinal trigeminal tract in the caudal
hindbrain, in which both bombesin/GRP preferring and
neuromedin-B preferring patterns were found (Ladenheim,
Jensen, Mantey, & Moran, 1992).
Examination of regional distributions of bombesin and
neuromedin-B demonstrates high densities of neuromedin-B
preferring binding sites located in the olfactory bulb and
anterior olfactory nucleus, amygdalopyriform transition,
amygdalohippocampal area, and lateral amygdala (Ladenheim,
Jensen, Mantey, & Moran, 1992).

Moderate densities of

neuromedin-B binding are found in the ventromedial
hypothalamic nucleus, stria terminalis, and medial
mammillary nucleus (Ladenheim, Jensen, Mantey, & Moran,
1992).

The lowest densities of neuromedin-B
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immunoreactivity are found in the infundibular stem, tuber
cinereum, and caudate (Ladenheim, Jensen, Mantey, & Moran,
1992).

In the thalamic areas, neuromedin-B exhibits high

densities in the paraventricular and posteromedian nuclei,
moderate densities in the central median, rhomboid,
reuniens, and intermediodorsal nuclei (Ladenheim, Jensen,
Mantey, & Moran, 1992).

Interestingly, there are no

thalamic nuclei that contained bombesin/GRP preferring
binding sites (Ladenheim, Jensen, Mantey, & Moran, 1992).
In the anterior forebrain regions, bombesin/GRP
preferring binding sites are mainly located in the
hippocampus, with high densities in the magnocellular
region of the paraventricular nucleus, arcuate,
suprachiasmatic nuclei, and lateral mammillary bodies
(Ladenheim, Jensen, Mantey, & Moran, 1992).

Additional

high density sites are found in the lateral and ventral
aspects of the bed nucleus of the stria terminalis and the
outer edge of the hippocampal oreins (Ladenheim, Jensen,
Mantey, & Moran, 1992) . Moderate densities of
bombesin/GRP-preferring sites are located in the molecular
layer of the hippocampus, and layers I-VI of the cortex
with the greatest densities in the parietal cortex
(Ladenheim, Jensen, Mantey, & Moran, 1992).
In the midbrain, moderate levels of
bombesin/GRP-preferring densities were found in the
reticular subdivision of the substantia nigra, and low
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levels of binding in the ventral tegmental region
(Ladenheim, Jensen, Mantey, & Moran, 1992).

Moderate

levels of neuromedin-B preferring binding sites were found
in the dorsal raphe, median raphe, and pontine nuclei
while the lateral and dorsomedial interpenduncular nucleus
exhibited high binding densities (Ladenheim, Jensen,
Mantey, & Moran, 1992).

Low levels of bombesin/GRP

preferring binding densities was found in the ventral
tegmental region, while low levels of neuromedin-B
preferring densities were identified in the dorsal cortex
of the inferior colliculus (Ladenheim, Jensen, Mantey, &
Moran, 19 92) .
In the hindbrain moderate densities of neuromedin-B
preferring binding sites were located in the lateral and
medial parabrachial nuclei, locus coeruleus, prepositus
hypoglossal nuclei, nucleus of the solitary tract, and the
periventricular grey of the dorsal rim of the fourth
ventricle (Ladenheim, Jensen, Mantey, & Moran, 1992).
High densities of bombesin/GRP preferring binding sites
were observed in the spinal trigeminal nucleus and nucleus
ambiguus, while moderate densities were seen in the
gigantocellular reticular nucleus (Ladenheim, Jensen,
Mantey, & Moran, 1992) .

The lowest densities of

bombesin/GRP preferring binding sites were observed in the
inferior olivary nucleus (Ladenheim, Jensen, Mantey, &
Moran, 1992).
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Studies performed using bombesin receptor antagonists
have demonstrated similar distributions of receptor
subtypes in the central nervous system (Ladenheim et a l .,
1993) and the periphery (Von Schrenck et a l ., 1990).
Clearly there is a wide spread distribution of at least
two known bombesin receptor subtypes both in the central
nervous and in peripheral tissues, specifically the
gastrointestinal tract.

PHYSIOLOGICAL ACTIONS OF BOMBESIN
Central Actions
Effect on the Autonomic Nervous System
Central administration of bombesin-like peptides
produces a variety of changes in autonomic nervous system
substrata.

Injection of bombesin into the intracerebral

ventricles (icv) produces a significant increase in plasma
levels of norepinephrine and epinephrine in the rat
(Brown, Carver & Fisher, 1988).

Centrally administered

bombesin has a markedly greater potential to induce
elevations in plasma epinephrine levels relative to
norepinephrine (Brown & Fisher, 1984).

Bilateral

adrenalectomy abolishes the increase in epinephrine that
follows central administration, suggesting that bombesin
stimulates brain regions which have neural influence on
the adrenal glands (Brown & Fisher, 1984; Brown, Tache, &
Fisher, 1979; Fisher & Brown, 1984).

The specific brain

region/s through which bombesin exerts its influence on
norepinephrine levels have not been located, but may be
the same site at which it regulates epinephrine levels,
which is the rostral aspect of the nucleus of the solitary
tract (Brown, Tache, & Fisher, 1979).

It is possible that

the brain site(s) responsible for this effect may be
anterior to, or project neural pathways through, the
lateral hypothalamus since lesions of the lateral
hypothalamus, or transections lateral or posterior to it
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attenuate bombesin-induced elevations of glucose found
secondary to adrenal stimulation (Gunion, Grijalva, Tache,
& Novin, 1984).
The stimulation bombesin exerts on the adrenal
medulla appears to be mediated by neural rather than
humoral events (Brown, 1981; Brown & Fisher, 1984; Brown,
Tache, & Fisher, 1979; Somiya Sc Tonoue, 1984).

Central

injection of bombesin has been demonstrated to increase
adrenal epinephrine secretion, inhibit gastric acid
secretion, and elevate heart rate and blood pressure via
sympathetic nervous system mediation (Brown Sc Tache,
1981).

In addition to adrenal modulation of metabolic

fuels, bombesin has been observed to significantly
suppress both vagal and sympathetic outflow to the stomach
while markedly stimulating activity in the laryngeal
branch of the vagus and the adrenal sympathetic nerve
(Somiya Sc Tonoue, 1984).
Bombesin has also been shown to have potent effects
on other parameters of autonomic function.

Injections of

bombesin into the lateral ventricles of rats results in a
reduction of the normal rise in heart rate and oxygen
consumption secondary to exposure to cold which may be
secondary to modification of a central mechanism
controlling cardiac function (Fisher, Cave, Sc Brown,
1985).

Additional research in this area illustrates that

central administration of bombesin produces elevations in
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mean arterial pressure, heart rate, and suppresses
cold-induced tachycardia (Fisher Sc Brown, 1984).

Only the

elevation in mean arterial pressure seen after bombesin
administration is attenuated by adrenalectomy (Fisher &
Brown, 1984), suggesting that the other changes seen were
secondary to neural rather than humoral mechanisms.
Central bombesin has also been found to modulate
respiratory function.

Bombesin icv produces elevations in

minute volumes in rats which are secondary to an overall
increase in respiratory rate and tidal volume, as well as
significant increases in sighing respiration (Niewoehner,
Levine, & Morley, 1983).
Rats treated with bombesin centrally do not exhibit
cold-induced accumulation of dopamine in the interscapular
b r o w n fat of rats treated w ith a dopamine (3-hydroxylase

inhibitor (Brown, Allen, & Fisher, 1987).

This finding

suggests that bombesin inhibits cold-induced sympathetic
outflow to brown fat.

This inhibition of dopamine

accumulation in brown fat in cold-exposed animals was
found to be a viscerotopically specific response, as
dopamine levels in other tissues were not effected (Brown,
Allen, Sc Fisher, 1987) .

Others have reported that animals

tested with bombesin at normal ambient temperatures
exhibit reduced interscapular brown fat thermogenesis
relative to core body temperatures (Shido, Noda, &
Nagasaka, 1987).
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Effect on the Gut
Central bombesin decreases both volume and
concentration of gastric secretions in conscious,
pylorus-ligated rats (Tache, Vale, Rivier, & Brown, 1980).
This effect is dose dependent, long lasting, and
reversible.

Bombesin injected into the cisterna magna

produces potent increases in mucus secretion from the
gastric wall in rats, which is of long duration (Tache,
Vale, Rivier, & Brown, 1980).

Intraventricular bombesin

produces a dose dependent inhibition of gastric emptying
and small intestine motility, while producing a transient
stimulation of, large intestine motility (Porreca & Burks,
1983; Porreca, Burks, & Koslo, 1985; Tache, Brown, &
Collu, 1979) and duodenal contraction frequency (Porreca,
Burks, & Koslo, 1985).

This effect appears to be mediated

by a disruption of normal peristaltic activity, rather
than a simple reduction in wave frequency since various
areas of the gastrointestinal tract are affected
differently.

The inhibition of gastric emptying seen in

rats receiving central bombesin is abolished by vagotomy
(Porreca & Burks, 1983).
A large number of studies have established the potent
ability of bombesin to inhibit gastric acid secretion
after central administration (Brown & Tache, 1981; Gunion,
Tache, Walsh, & Novin, 1984; Tache, 1985; Tache, Lesiege,
& Goto, 1986; Tache, Vale, Rivier, & Brown, 1980; Tache,
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Vale, Rivier, & Brown, 1981; Yang, Cuttitta, Raybould, &
Tache, 1989).

Reports indicate that bombesin injected

into the lateral ventricles (Brown & Tache, 1981; Gunion,
Tache, Walsh, & Novin, 1984;

Tache, 1985; Tache, Lesiege,

& Goto, 1986; Tache, Vale, Rivier, & Brown, 1980; Tache,
Vale, Rivier, & Brown, 1981) or administered intrathecally
(Yang, Cuttitta, Raybould, & Tache, 1989), reliably
suppresses gastric acid secretion in rats.

This reduction

in gastric acid secretion results in a general increase in
gastric pH, and is not attenuated by abdominal vagotomy
(Tache, Lesiege, & Goto, 1986), nor do prostaglandin or
opioid pathways mediate this activity (Tache, 1985) .
Lesions of the ventromedial hypothalamus do not attenuate
bombesin-induced reductions in acid secretion (Gunion,
Tache, Walsh, & Novin, 1984).

Interestingly,

intracisternal injection of bombesin produces a long
lasting and robust increase in serum gastrin levels
(Tache, Marki, Rivier, Vale, & Brown, 1981; Tache, Vale,
Rivier, & Brown, 1980).

It has been reasoned that

bombesin inhibits the acid secretory effect of endogenous
gastrin by elevating gastric pH.

It has also been

suggested that bombesin produces changes in gastric acid
secretion by excitation of the sympatho-adrenomedullary
system (Okuma, Yokotani, & Osumi, 1987).

The exact

mechanism by which bombesin influences gastric pH remains
unclear.
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Endocrine Effects
Central bombesin has been found to modulate the
secretion of a wide variety of endocrine products.
Bombesin injection into the central nervous system
increases serum glucose, free fatty acids, and
corticosterone levels (Babcock, Barton, Gunion, &
Rosenthal, 1992; Gunion et al., 1989).

The ability of

central administration of bombesin to induce hyperglycemia
has been well established (Brown, Tache, & Fisher, 1979;
Gunion, Grijalva, Tache, & Novin, 1984; Brown, 1981).
This effect appears to be mediated by bombesin-induced
stimulation of epinephrine from the adrenal medulla
(Brown, Tache, & Fisher, 1979).

Adrenalectomy, but not

hypophysectomy prevents bombesin-induced hyperglycemia,
further supporting the role of the adrenals in this event
(Brown, Tache, & Fisher, 1979).

In addition to inducing

hyperglycemia, central administration of bombesin results
in elevations of serum epinephrine (Brown & Fisher, 1984),
hyperglucagonemia, and relative hypoinsulinemia, with
insignificant effect on dopamine or norepinephrine (Brown,
1981; Brown, Tache, & Fisher, 1979).

Brown has suggested

that bombesin-induced changes seen in glucose, glucagon,
and insulin levels are secondary to the release of adrenal
epinephrine

(Brown, 1981).

Additionally, it has been

demonstrated that lesions of the lateral hypothalamus or
transections of the lateral or posterior borders of the
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lateral hypothalamus block bombesin-induced hyperglycemia
(Gunion, Grijalva, Tache, & Novin, 1984) .

These findings

would suggest that bombesin produces these effects by
acting on brain sites which are adjacent to, or project
neural efferents through, the lateral hypothalamus.
Bombesin also inhibits stress-induced elevations in
prolactin while having no effect on corticosterone, growth
hormone, or lutenizing hormone in one study (Tache, Brown,
& Collu, 1979), while others have demonstrated that
gastrin-releasing peptide suppresses growth hormone
secretion (Pinski et a l ., 1992), and bombesin elevates
serum corticosterone levels (Babcock, Barton, Gunion, &
Rosenthal, 1992; Gunion et al., 1989).

The disparity

between these findings may be related to the fact that in
the stressed animals these hormone levels could have been
maximally stimulated, and thereby resistant to the effects
of bombesin.

Peripheral Actions of Bombesin
Effect on Smooth Muscle
When administered peripherally, bombesin has a potent
effect on smooth muscle including the intestine, blood
vessels, urinary bladder, and uterus (Erspamer, Erpamer, &
Inselvini, 1970; Erspamer, Erspamer, Inselvini, & Negri,
1972).

These effects vary between species; dogs, cats,

rabbits, and rats experience an increase in blood pressure
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and smooth muscle tone, while primates experience a
decrease in blood pressure (Erspamer, Erspamer, Inselvini,
& Negri, 1972).

Additionally, intravenous administration

of bombesin produces dose-dependent increases in mean
arterial pressure and heart rate in rats (Bayorh &
Feuerstein, 1985).
Effect on the Gut
Bombesin injected either subcutaneously or
intravenously stimulates secretion of gastric acid as well
as pepsin from the fundus of denervated stomach in the dog
(Bertaccini, Erspamer, & Impicciatore, 1973).
alters gastric motility in rats, dogs, and man.

Bombesin
In the

rat, bombesin induces spasmogenic activity independent of
the autonomic nervous system (Bertaccini & Impicciatore,
1975).

In man, bombesin exerts a contractile effect on

the antrum and the pylorus while having an inhibitory
effect on motility on the stomach body and the fundus
(Bertaccini & Impicciatore, 1975).

While bombesin has

potent effects on the motility of the stomach tissue,
there is no effect of bombesin on gastric emptying
(Hostetler, McHugh, & Moran, 1989).

Additionally,

bombesin has been demonstrated to have potent stimulatory
effects on the rat colon (Erspamer, Erpamer, & Inselvini,
1970).
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Endocrine Effects
Bombesin has been found to produce several changes in
endocrine function when administered peripherally.
Intravenous bombesin injections into food-deprived baboons
produces an elevation of plasma insulin levels without
changing plasma glucose (Woods, Stein, Figlewicz, & Porte,
Jr., 1983).

When animals are allowed to feed after

bombesin injection there is a reduction in plasma insulin
after completion of the feeding interval (Woods, Stein,
Figlewicz, & Porte, Jr., 1983).

In addition,

intravenous administration of bombesin increases plasma
glucagon levels in the dog (Kaneto, Kaneko, Nakaya,
Kajinuma, & Kosaka, 1978; Vaysse et al., 1981) and
suppresses the post-prandial rise in serum glucose (Woods,
Stein, Figlewicz, & Porte, Jr., 1983).
It appears that bombesin exerts a potent effect on
pancreatic tissues.

In dogs, systemic administration of

bombesin produces an increase in pancreatic polypeptide in
a fashion similar to ingestion of a meal of meat
(Konturek, Konturek, Bielanski, & Szewczyk, 1989).

This

increase in pancreatic polypeptide can be blocked by the
cholecystokinin antagonist, L-364,718 (Konturek, Konturek,
Bielanski, & Szewczyk, 1989).

This would suggest that

bombesin produces this effect via activation of endogenous
cholecystokinin.

Treatment of pancreatic tissue with

bombesin results in increased amylase release (Lee,
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Jensen, & Gardner, 1980), which can be blocked with a
bombesin antagonist (Sekar, Uemura, Coy, Hirschowitz, &
Dickinson, 1991).

These results have been replicated in

conscious rats with chronic pancreatic fistula (Jaworek,
Konturek, Konturek, Cai, & Schally, 1992).

Bombesin

stimulates a rapid increase in the concentration of free
cytosolic calcium ions which is believed to be, in part,
responsible for bombesin effect on stimulation of
pancreatic enzymes (Pandol & Mendius, 1988).
In isolated tissue preparations, bombesin has been
shown to stimulate somatostatin release as well as gastrin
(DuVal et a l ., 1981).

In conscious dogs, intravenous

bombesin increases somatostatin-like immunoreactivity,
which can be partially attenuated by administration of
atropine sulfate (De Graef & Woussen-Colle, 1985)
implicating, at least in part, a cholinergic mechanism.
The increase in gastrin release by bombesin in isolated
tissue (Azuma, Taggart, & Walsh, 1987; DuVal et a l ., 1981)
has also been reproduced in dogs (Bertaccini, Erspamer,
Melchiorri, & Sopranzi, 1974).

In addition to its other

endocrine effects, bombesin has been found to regulate the
release of cholecystokinin from the small intestine
(Bertaccini, Erspamer, & Impicciatore, 1973) and stimulate
the release of prostaglandins from isolated rabbit ear
preparations (Juan, Sametz, Petronijevic, & Lembeck,
1984) .
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Other Effects
Bombesin administered peripherally enhances memory
retention in rats (Flood & Morley, 1988).

This is

attenuated by vagotomy, suggesting that an ascending vagal
pathway participates in this event (Flood & Morley, 1988).
This finding is similar to those of previous reports which
implicate feeding in the enhancement of memory and
suggests that this event is not specifically due to
feeding, but is reliant on the stimulation of
gastrointestinal peptides by food intake.

Peripheral

bombesin treatment also enhances slow wave sleep (de Saint
Hilaire-Kafi, Gibbs, & Nicolaidis, 1989).
Bombesin has been found to produce other changes
after peripheral administration.

Intraperitoneal

injection of bombesin in rats increases metabolism, as
measured by computerized open circuit respirometer (Even,
de Saint Hilaire, & Nicolaidis, 1991).

The existence of

bombesin in the periphery has also been linked with
several types of neoplasms, and is believed to act as a
growth factor in these tissues (Wiedermann, Ruff, & Pert,
1988).

Included in these neoplasms are testicular cancer

(Fathi et al., 1993), small cell lung carcinoma (Kane et
a l ., 1991; Wiedermann, 1989), and glioblastoma (Wang et
a l ., 1992).

BEHAVIORAL ACTIONS OF BOMBESIN
Effect of Central Bombesin on Feeding
Administration of bombesin produces a reduction in
food intake under a variety of paradigms (Avery &
Calisher, 1982; Babcock, Avery, & Maitland, 1985; Babcock
& Barton, 1990; Babcock, Barton, Gunion, & Rosenthal,
1992;

Babcock, Barton, Perez, & Hearndon, 1989; Barton &

Babcock, 1990; Calisher & Avery, 1984; Gibbs, Kulkosky, &
Smith, 1981; Kulkosky, 1988; Kulkosky, Gibbs, & Smith,
1982;

Ladenheim & Ritter, 1988; Merali et a l ., 1988;

Merali, Moody, & Coy, 1993; Oku, Inoue, Glick, Bray, &
Walsh, 1984; Stuckey & Gibbs, 1982).

Specifically,

intraventricular bombesin suppresses feeding in acutely
deprived rats allowed food access after bombesin treatment
(Avery & Calisher, 1982; Babcock, Avery, & Maitland, 1985;
Babcock, Barton, Perez, & Hearndon, 1989; Barton &
Babcock, 1990; Gibbs, Kulkosky, & Smith, 1981; Kulkosky,
1988;

Kulkosky, Gibbs, & Smith, 1982; Ladenheim & Ritter,

1988).

Bombesin has also been established to inhibit

feeding when injected into individual brain regions.
Bombesin injection into the lateral hypothalamus (Stuckey
& Gibbs, 1982), substantia nigra (Calisher & Avery, 1984),
preoptic area of the hypothalamus (Babcock, Barton,
Gunion, Sc Rosenthal, 1992), and hypothalamic
paraventricular nucleus (Babcock Sc Barton, 1990) produces
significant reductions in food intake.
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In multiple
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studies, central injections of bombesin have been found to
suppress operant responding for both food and water
(Babcock, Avery, & Maitland, 1985; Gibbs, Kulkosky, &
Smith, 1981; Kulkosky, Gibbs, & Smith, 1982), while in
others it was found to be specific to food reward (Avery &
Calisher, 1982; Stuckey & Gibbs, 1982).

These findings

have brought some researchers to the belief that bombesin
may act as a potential aversive agent when administered
centrally.

Kulkosky and colleagues (Kulkosky, Gibbs, &

Smith, 1982) reported an increase in grooming after
central doses of bombesin which suppress food intake.

Yet

other behaviors common to feeding, but not specific
parameters of consumption, such as chewing, are not
altered by intraventricular injections of bombesin
(Morley, Levine, Murray, Knelp, & Grace, 1982) .

Other

data would lend additional support to the belief that
bombesin does not create an aversive state when
administered centrally.

Bombesin does not produce a

conditioned taste aversion at doses which have been
reported to suppress food intake (Kulkosky, Gray, Gibbs, &
Smith, 1981).

Additionally, low doses of bombesin which

suppress feeding induce changes in grooming and locomotion
closely related to those seen under conditions of normal
satiety (McCoy & Avery, 1990).

The most convincing

evidence to support the hypothesis that central bombesin
may act as a satiety agent comes from findings that very
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low doses into the fourth ventricle produce reductions in
feeding with no increase in grooming or locomotion
(Ladenheim & Ritter, 1988), that increases in
bombesin-like peptide activity in the hypothalamus and
hippocampus occur after feeding (Kateb & Merali, 1992),
and that newly developed bombesin receptor antagonists
injected centrally result in increase food intake (Merali,
Moody, & Coy, 1993).

Thus, evidence exists suggesting

that bombesin may mimic a possible satiety action of
gastrin-releasing peptide by acting on central receptor
sites, and that while having potent anorectic effects in a
variety of brain regions, specific changes in behavior
related to reductions in feeding and potential satiety may
be controlled by periventricular areas.

One theory that

has been forwarded, is that bombesin acts both within the
central nervous system and periphery to integrate events
associated with regulation of food intake, development of
satiety, and satiety related behaviors (McCoy & Avery,
1990).

Effect of Peripheral Bombesin on Feeding
Unlike the case with central bombesin injections,
there appears to be a much greater agreement among
researchers that peripheral administration of bombesin
produces satiety without aversion or malaise (McCoy &
Avery, 1990).

Peripheral administration of bombesin
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inhibits food intake in food-deprived rats (Flood, Silver,
& Morley, 1990; Gibbs, 1985; Gibbs et al., 1979; Gibbs,
Kulkosky, & Smith, 1981; Gibbs & Smith, 1982; Hostetler,
McHugh, & Moran, 1989; Kulkosky & Gibbs, 1982; Kulkosky,
Gibbs, & Smith, 1982; Kulkosky, Gray, Gibbs, & Smith,
1981; Wager-Srdar, Morley,

& Levine, 1986), rats with

lesions of the ventromedial hypothalamus (Geary, Smith, &
Gibbs, 1 9 8 6 ) ,

rats induced to eat by opioids (Morley,

Levine, Kneip, Grace, & Billington, 1983), or acute stress
(Morley & Levine, 1981), as well as in mice (Silver, Flood,
& Morley, 1988), hamsters (Miceli & Malsbury, 1985), wolf
pups (Morley, Levine, Hertel, Tandeski, & Seal, 1986),
baboons (Woods, Stein, Figlewicz, & Porte, Jr., 1983),
dogs (Levine, Sievert, Morley, Gosnell, & Silvis, 1984),
and humans (Muurahainen, Kissileff, Thornton, & Pi-Sunyer,
1983).

While Deutsch has asserted that bombesin may

produce satiety via production of aversion (Deutsch &
Parsons, 1981), there is evidence against this suggestion.
Research has revealed a fixed sequence of
behaviors which are characteristic of satiety in the rat
(Antin, Gibbs, Holt, Young, & Smith, 1975).

These

behavioral parameters are: Termination of feeding, short
term grooming and exploration, followed by rest or sleep
(Antin, Gibbs, Holt, Young, & Smith, 1975).

Peripheral

administration of bombesin elicits a sequence of events
associated with normal satiety such as, grooming,
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sniffing, locomotion, and rearing, followed by withdrawal
from the site of feeding and rest or sleep (Gibbs, 1985;
Gibbs, Kulkosky, & Smith, 1981).

Additionally, bombesin

reduces operant responding for food as a reward (Babcock,
Avery, & Maitland, 1985; Flood, Silver, & Morley, 1990),
indicating a reduction of hunger.

Peripherally

administered bombesin is equally potent at suppressing
both liquid and solid meals (Gibbs et a l ., 1979), while
not suppressing intake of water (Kulkosky, Gibbs, & Smith,
1982; Kulkosky, Gray, Gibbs, & Smith, 1981).

The

suppression of feeding observed after peripheral bombesin
administration is not due to changes in gastric emptying
(Gibbs & Smith, 1986; Hostetler, McHugh, & Moran, 1989),
and does not require vagal innervation of the stomach to
produce these effects (Gibbs & Smith, 1986; Morley,
Levine, Kneip, & Grace, 1982; Smith, Jerome, & Gibbs,
1981).

Added evidence for peripheral bombesin as a

satiety agent are the findings that it elicits satiety in
sham fed rats (Martin & Gibbs, 1980), and that it does not
produce a conditioned taste aversion (Kulkosky, Gray,
Gibbs, & Smith, 1981).

There is additional evidence that

suggests bombesin suppresses food intake independent of
peripheral release of cholycystokinin (Gibbs & Smith,
1986).

While the exact site through which peripheral

bombesin produces satiety is unknown, there is data to
suggest that it acts on receptors in the gut to modulate
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feeding.

Bombesin-like immunoreactivity has been well

demonstrated in the gastrointestinal tract (Brown, Allen,
Villarreal, Rivier, & Vale, 1978).

Perfusion of the

celiac artery with bombesin produces suppression of
feeding more so than perfusion of the superior mesenteric
artery, or when injected intraperitoneally (Kirkham,
Gibbs, & Smith, 1991) .

Since the celiac arterial blood

supply perfuses the stomach, pancreas, liver, spleen, and
proximal duodenum, it would seem likely that one or more
of these organs may provide a primary site of bombesin
action on feeding in the periphery.

While the vagal

innervation of the stomach is not necessary for bombesin
to produce reduction in feeding, there is evidence for a
gut brain axis of action.

Complete neural disconnection

of the gut from the brain blocks bombesin-induced satiety
(Stuckey, Gibbs, & Smith, 1985) and peripheral treatment
with capsaicin, a neurotoxin known to destroy small
diameter sensory neurons, attenuates bombesin-induced
suppression of feeding (Ladenheim & Ritter, 1991).
One way bombesin may produce reductions in feeding is
by modulating sympathetic activity.

Many peptides which

modulate food intake do so in a reciprocal relationship to
their effects on sympathetic nervous system activity
(Bray, 1993).

Bray has suggested that peptides that

attenuate feeding may do so by increasing sympathetic
activity (Bray, 1992).

The exact mechanism by which
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bombesin may modulate sympathetic activity is unclear.
Adrenalectomy abolishes obesity in a variety of
experimental paradigms (Tokunaga et a l ., 1989; Holt &
York, 1989), and glucocorticoids have been shown to be
necessary components of overeating and obesity (Brown &
Fisher, 1986).

It appears that adrenalectomy increases

sympathetic activity by removing negative feedback
modulation of corticotrophin-releasing hormone, thus
reversing over consumption and obesity (Vander Tuig,
Ohshima, Yoshida, Romsos, & Bray, 1984).

While

adrenalectomy attenuates some of the behavioral effects of
bombesin (Hawkins & Avery, 1983), and peripheral bombesin
stimulates adrenal function (Brown, Tache, & Fisher, 1979;
Okuma, Yokotani, & Osumi, 1987), the adrenal glands are
not necessary for bombesin-induced suppression of feeding
(Gibbs, Kulkosky, & Smith, 1981), indicating an
extra-adrenal site for possible peripheral bombesin
modulation of sympathetic activity.

Effect of Bombesin on Drinking
Central bombesin administration has been demonstrated
to suppress drinking in rats at doses that are
insufficient to attenuate feeding (Kulkosky, Gibbs, &
Smith, 1982).

In fact, the majority of reports of

investigation of intraventricular bombesin administration
on drinking reveals that, with the exception of one
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(Ladenheim & Ritter, 1988), all tested paradigms have
consistently demonstrated bombesin-induced reductions of
water consumption (Babcock, Avery, & Maitland, 1985; de
Caro, Massi, Micossi, & Perfumi, 1984; Gibbs, Kulkosky, &
Smith, 1981; Kulkosky, Gibbs, & Smith, 1982; Miceli &
Malsbury, 1985).

Additional evidence has shown that site

specific microinjections of bombesin into the lateral
hypothalamus, nucleus caudatus putamen, and olfactory
tubercle suppress drinking (Willis, Hansky, & Smith,
1984), while others have demonstrated findings contrary to
these (Stuckey & Gibbs, 1982).

Clearly the preponderance

of evidence implicates central administration of bombesin
in reduction of drinking behavior.

As reported in

examining the central effects of bombesin on feeding, the
primary explanation for this reduction in drinking is
attributed to marked increases in grooming and other
competitive behaviors (Miceli & Malsbury, 1985).

The

exact mechanism by which central bombesin exerts this
suppression of drinking remains unknown, but may be
related to potential aversive effects.
Findings with peripheral administration of bombesin
stand in contrast to those under central administration.
In experiments designed to examine the effects of bombesin
on feeding and drinking behavior, peripheral
administration of bombesin at doses which were
demonstrated to suppress feeding failed to alter drinking
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(Kulkosky, Gibbs, & Smith, 1982; Kulkosky, Gray, Gibbs, &
Smith, 1981; Miceli & Malsbury, 1985).

To date, there are

no published reports of peripheral bombesin administration
resulting in reductions of water consumption.

Effect of Bombesin on Grooming and Locomotion
Rats given bombesin centrally typically display a set
of stereotypies which include: forepaw tremors,

"wet-dog"

shakes, and excessive grooming (Brown, Rivier, & Vale,
1977).

The excessive grooming behavior is characterized

by scratching of the head and neck with both forepaw and
hindpaw, as well as bathing with saliva.

Kulkosky has

suggested that bombesin may act as an afferent
somatosensory neurotransmitter, and that grooming produced
by central administration of bombesin may reflect a
response to alteration of cutaneous sensation (Kulkosky,
1988).

This increased grooming following central bombesin

is also associated with the suppression of feeding seen
under these conditions (Kulkosky, Gibbs, & Smith, 1982).
In addition, the pattern of behaviors observed after
central bombesin do not completely duplicate the behaviors
that follow normal satiety, resting decreases while
grooming increases (Kulkosky, Gibbs, & Smith, 1982) .
These changes in behavior are not observed after
peripheral bombesin (Kulkosky, Gibbs, & Smith, 1982).
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The stereotypies produced by central administration
of bombesin appear to be mediated in part by dopaminergic
neurons.

Increased grooming behavior caused by central

bombesin can be attenuated by peripheral administration of
fluphenazine and haloperidol (Moody, Merali, & Crawley,
1988).

Additional support for this theory is found in

data which demonstrates that bombesin-induced grooming
abnormalities are abolished by depletion of dopaminergic
neurons using 6-dihydroxytryptamine (Moody, Merali, &
Crawley, 1988).

In addition to a possible dopaminergic

axis of bombesin-induced grooming, it is also known that
the anxiolytics, diazepam and chlordiazepoxide reverse it
as well, implicating a potential involvement of
benzodiazepine receptors (Crawley & Moody, 1983; Moody,
Merali, & Crawley, 1988).
It has been suggested that the excessive grooming
associated with central bombesin administration may
represent a behavioral attempt to reduce stress associated
with activation of the sympathetic nervous system (Crawley
& Moody, 1983).

One of the behavioral effects of central

bombesin administration is increased locomotion (Pert,
Moody, Pert, Dewald, & Rivier, 1980).

As previously

described in bombesin-induced grooming, it has been found
that aberrations in bombesin-induced locomotion can be
abolished with dopamine antagonists (Pert, Moody, Pert,
Dewald, & Rivier, 1980).

While the exact mechanism by
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which bombesin produces these behavioral changes is not
known, there appears to be an implication of dopaminergic
neurons and/or pathways.

Interestingly, examination of

bombesin-induced hypothermia and hypophagia after
microinjection into the substantia nigra, an area critical
in dopamine control of motor function, failed to mention
any abnormalities in grooming or locomotion (Calisher &
Avery, 1984) .

BOMBESIN AND THERMOREGULATION
Introduction to Nonshivering Thermogenesis
All mammals are homeothermic, and must maintain their
internal body temperature within a narrow range so as to
promote optimal homeostasis.

There are a variety of

factors which impact the regulation of body temperature in
homeotherms.

Because of this, a brief review of

thermogenic systems and thermoregulatory balance is in
order.
Several mechanisms provide synergistic effects in the
regulation of temperature in homeotherms.

One primary

thermoregulatory effector is metabolic thermogenesis.
Gordon (Gordon, 1990), describes metabolic thermogenesis
as being comprised of two primary parts.

One component is

shivering thermogenesis, in which generation of heat is
accomplished by erratic skeletal muscle movements which
are not under voluntary control (Gordon, 1990).

This form

of thermogenesis occurs when an animal is placed in an
environment which has an ambient temperature below which
normal resting metabolism will not produce sufficient heat
to compensate for heat loss (Gordon, 1990).
A second component of metabolic thermogenesis is
nonshivering thermogenesis, which is accomplished by
activation of special brown adipose tissues commonly found
in the interscapular area in rats (Himms-Hagen, 1984), as
well as cervical, pericardial, intercostal, and perirenal
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areas (Gordon, 1990).

Brown adipose tissue is under

control of the sympathetic nervous system, and is
stimulated to produce heat by both direct innervation and
circulating catecholamines (Landsberg, Saville, & Young,
1984).

Norephinephrine released from the sympathetic

nerves which innervate the brown adipose tissue is the
primary initiator of heat production in response to
exposure to temperatures below thermoneutrality (Gordon,
1990).

Nicholls (Nicholls & Locke, 1984), suggests that

in cold exposure the following events are believed to be
responsible for acute thermogenesis in brown adipose
tissue: 1) norepinephrine binds to the beta receptors, 2)
cyclic adenosine monophosphate levels in the cytosol rise,
3) a protein kinase is activated, 4)

lipase is

phosphorylated and activated, 5) fatty acids are liberated
and activated to acylcarnitine, 6) respiratory control
inhibits the oxidation of acylcarnitine, and the
acylcarnatine and acetyl coenzyme-A pools fill, 7) free
fatty acids accumulate, reversing the nucleotide
inhibition of the 32,000-Mr (uncoupling) protein, 8)
producing an increased proton conductance which allows
acylcarnitine to be oxidized, and produces a steady-state
concentration of fatty acids with a balance between
lipolysis and oxidation.

Another thermoregulatory

effector is peripheral vasomotor tone.

When blood vessels

dilate in response to cutaneous cooling, a correlated
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increase in metabolism occurs (Gordon, 1990) .

This

vasodilation provides increased circulation to the
cutaneous tissues resulting in warming of the periphery.
Vasodilation in ambient temperatures below
thermoneutrality results in heat dissipation (Gordon,
1987).

At temperatures above thermoneutrality, increased

vasodilation can result in transfer of environmental
energy into the animal, resulting in hyperthermia (Bruck &
Zeisberger, 1987).
In addition, evaporative water loss from an organism
represents another thermoregulatory effector (Gordon,
1990).

As water evaporates, surface cooling takes place.

This type of evaporative loss may be passive, such as in
the evaporation which takes place under normal
respiration, or it may be active, as in the case when
rodents spread saliva on their fur to enhance evaporative
cooling (Gordon, 1990).
The final and perhaps most common of all
thermoregulatory effectors is behavioral actions in which
an animal protects its critical body temperature (Gordon,
Lee, Chen, Killough, & Ali, 1991).

Methods which allow

animals to behaviorally influence their body temperature
is the use of gradient chambers (Gordon, Lee, Chen,
Killough, & Ali, 1991) or operant training for heat
reinforcement or heat escape (Hawkins & Avery, 1983).
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The event of heat loss or gain can be derived from
the "heat balance equation" which comes from the First Law
of Thermodynamics (Gordon, 1990).

This equation describes

the net exchange of heat energy between an organism and
its environment.

When a homeothermic organism is at rest,

heat balance can be described as: S = M + E + R + C + K
Where: S = net rate of heat storage; M = metabolic heat
production; E = net rate of evaporative heat exchange; R =
net rate of radiant heat exchange; C = net rate of
convective heat transfer; and K = net rate of conductive
heat transfer (Gordon, 1990).

If heat production exceeds

heat loss then S is a positive value, and the animals
becomes hyperthermic, whereas if heat loss exceeds
production S is a negative value (Gordon, 1990) .

A

condition of thermal equilibrium is reached when heat loss
and heat production are equal (Gordon, 1990).

Thus,

hypothermia and hyperthermia can be explained in component
parts.

In the heat balance equation only one factor,

metabolism, accounts for internal heat production while
several other factors may act simultaneously to contribute
or detract from heat storage.

Under conditions where

ambient temperatures are below thermoneutrality, these
other factors generally account for heat loss.

At

temperatures above thermoneutrality these same factors
contribute to heat gain.
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Bombesin in the Cold-Exposed Rat
Central injections of bombesin produce hypothermia in
cold-exposed rats (Babcock, Barton, & Keene, 1989; Brown,
1981; Brown, Rivier, & Vale, 1977; Francesconi & Mager,
1981; Hawkins & Avery, 1983; Lin & Lin, 1986; Pittman,
Tache, & Brown, 1980; Rivier & Brown, 1978; Tache,
Pittman, & Brown, 1980; Wakabayashi, Tonegawa, &
Shibasaki, 1983; Wunder, Hawkins, Avery, & Swan, 1980)].
Injections of bombesin into the preoptic area of
hypothalamus have been shown to be effective in producing
hypothermia in cold-exposed rats (Lin & Lin, 1986;
Pittman, Tache, & Brown, 1980; Wunder, Hawkins, Avery, &
Swan, 1980).

This is an area known to contain

thermosensitive neurons (Nakayama, 1985), be an important
site for regulation of core body temperature (Cantor &
Satinoff, 1976; Satinoff & Rutstein, 1970), and play an
active role in stimulation of thermogenesis via brown
adipose tissue (Amir & De Blasio, 1991).

It has been

suggested that bombesin-induced hypothermia in
cold-exposed rats may represent an inhibition of
regulatory heat production (Brown, 1981; Brown, Allen, &
Fisher, 1987; Lin & Lin, 1986).

There is also evidence

that centrally administered bombesin may reduce metabolism
in the cold-exposed animal.

Central bombesin produces a

reduction in oxygen consumption in cold-exposed rats
(Brown, 1981; Lin & Lin, 1986; Shido, Noda, & Nagasaka,
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1987; Wunder, Hawkins, Avery, & Swan, 1980), prevents
increased oxygen consumption associated with cold-exposure
(Brown, 1982), and impairs the cold-induced increase of
dopamine accumulation in the interscapular brown adipose
tissue, but not other tissues, in rats treated with a
dopamine (J-hydroxylase inhibitor (Brown, Allen, & Fisher,
1987).

Additionally, bombesin causes hypothermia without

altering heat loss as measured by cutaneous temperatures
(Lin & Lin, 1986) .
The exact mechanism by which bombesin induces
hypothermia at temperatures below thermoneutrality is
unclear.

Findings have established that

thyrotropin

releasing factor, prostaglandin E2, and naloxone reverse
bombesin-induced hypothermia in cold-exposed animals
(Brown, Rivier, & Vale, 1977).

Additionally, bombesin

prevents cold-induced secretion of thyrotropin stimulating
hormone, while not preventing thyrotropin releasing
factor-induced secretion of thyrotropin stimulating factor
(Rivier & Brown, 1978).

This implicates a pituitary axis

of bombesin control of thyrotropin stimulating hormone.
Yet, bombesin injected centrally produces hypothermia in
cold-exposed rats that have been hypophysectomized
(Rasler, 1983).

The latter data would indicate that

bombesin-induced hypothermia in animals exposed to cold is
not dependent on centrally mediated release of pituitary
hormones.
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Given the previously mentioned information about
bombesin-induced hypothermia in animals tested at
temperatures below thermoneutrality, it would appear that
bombesin likely produces hypothermia by interfering with
compensatory heat production.

The agents known to reverse

bombesin-induced hypothermia under these conditions all
contribute to increased metabolism.

Knowing that energy

balance is a sum of heat production and heat loss, and
that bombesin has been repeatedly determined to reduce or
impair metabolism as measured by oxygen consumption in
cold-exposed rats, it would appear that bombesin most
likely produces hypothermia by reducing heat production.
Yet, there is evidence to the contrary.

Bombesin injected

centrally has been found to increase tail skin
temperatures in animals at normal ambient temperatures
(Lin Sc Lin, 1986; Tache, Pittman, Sc Brown, 1980).

While

these findings are not apparent at temperatures below
thermoneutrality, it does not preclude heat loss as a
mechanism by which bombesin may induce hypothermia.

Tache

has suggested that bombesin may act to produce hypothermia
in cold-exposed conditions by essentially making the
animals poikilothermic, and that change in body
temperature is dependent upon ambient temperatures (Tache,
Pittman, Sc Brown, 1980).

In support of this are findings

that bombesin selectively stimulates warm-responsive
neurons in the preoptic anterior hypothalamic area (Lin Sc

44

Lin, 1986).

This type of activation of warm-responsive

neurons would result in vasodilation and other
physiological changes to promote heat loss (Boulant &
Dean, 1986).

Under this type of activity it would seem

likely that ambient temperature would then influence core
body temperature.

Increased blood flow to cutaneous areas

would allow for transfer of heat across a gradient.

In

cold-exposed animals heat would be lost to the environment
while animals tested at temperatures above the upper level
of thermoneutrality would gain heat.

Additionally,

animals kept at ambient temperatures approximating normal
body temperatures would not experience a transfer of heat
energy.

This type of thermal exchange in core body

temperatures has been found to exist in animals
administered bombesin centrally.

Tache and colleagues

(Tache, Pittman, & Brown, 1980) found that central
bombesin produced hypothermia in animals tested at an
ambient temperature of 4° C, hyperthermia at an ambient
temperature of 3 6° C, and euthermia at an ambient
temperature of 31° C.

Additionally, bombesin treated

animals which become hyperthermic at temperatures above
thermoneutrality can be made hypothermic by transfer to a
cold environment (Tache, Pittman, & Brown, 1980).
It has been suggested that bombesin may alter
thermoregulatory “set point"; a core body temperature
established by central mechanisms which an animal will
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attempt to defend (Avery & Calisher, 1982; Wunder,
Hawkins, Avery, & Swan, 1980).

Animals trained to bar

press for heat escape, do so more frequently after central
bombesin administration (Avery, Hawkins, & Wunder, 1980) .
Avery reasons that this response is a behavioral attempt
to protect a lowered thermoregulatory

set point.

Given

that bombesin activates warm-responsive neurons, as
previously demonstrated (Lin & Lin, 1986), then it would
seem plausible that these animals may "feel" warm, and
thus bar press to escape heat.

In support of this,

animals administered bombesin centrally have been found to
select ambient temperatures in gradients significantly
lower than saline injected animals (Stump, McCoy, & Avery,
1990).

Yet, in the case of bar pressing for defense of an

altered set point, there is contrary data.

It has been

found that adrenalectomy abolishes increased bar pressing
for heat escape in bombesin treated animals tested at
temperatures below thermoneutrality (Hawkins & Avery,
1983).

Hawkins reasons that bombesin produces an increase

in behavioral activation secondary to stimulation of the
adrenal glands.

This seems unlikely due to findings that

central bombesin results in decreased bar pressing for
food reward (Babcock, Avery, & Maitland, 1985) ,

If

bombesin simply increases rewarded behavior, then it would
follow that this response would be generalized to other
paradigms, which is not the case.

Furthermore,
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adrenalectomy is known to increase thermogenesis in brown
adipose tissue (Kim & Romsos, 1990).

This may have been

the case as none of the animals tested by Hawkins ever
actually displayed hypothermia (Hawkins & Avery, 1983).
In fact, adrenalectomized rats did not display any
differences in heat escape after central bombesin versus
control treatment (Hawkins & Avery, 1983), which was quite
probably because they were euthermic.
Provided the previous findings related to
bombesin-induced hypothermia in animals tested at
temperatures below thermoneutrality, the underlying
mechanism is still not proven.

There is evidence which

suggests that central bombesin injections may produce
hypothermia by activation of brain mechanisms, thereby
disrupting metabolic processes or increasing heat loss via
peripheral vasodilation.

In addition there is evidence

that bombesin may alter central mechanisms in a way such
that an animal displays behaviors that appear to be
directed toward defense of a lowered core body
temperature.

The possibility that more than one of these

factors may influence bombesin-induced hypothermia in cold
environments has not been ruled out.

Bombesin-Induced Hypothermia at
Normal Ambient Temperatures
Central injection of bombesin was first reported to
produce hypothermia in rats tested at normal ambient
temperatures in 1980

(Tache, Pittman, & Brown, 1980) .

It

was later reported that bombesin-induced hypothermia in
animals tested near thermoneutrality was associated with
no change in metabolic rate as measured by oxygen
consumption (Brown, 1981; Wunder, Hawkins, Avery, & Swan,
1980).

While some data exists suggesting that hypothermia

observed under these conditions is not dependent upon
manipulation of food intake (Tache, Pittman, & Brown,
1980; Wunder,

Hawkins, Avery, & Swan, 1980), others were

unable to replicate these findings (Avery & Calisher,
1982;

Babcock & Barton, 1989; Babcock & Barton, 1990;

Babcock, Barton, Gunion, & Rosenthal, 1992; Babcock,
Barton, & Keene, 1989; Babcock, Barton, Perez, & Hearndon,
1989;

Barton & Babcock, 1990; Barton & Hawkins, 19 93;

Calisher & Avery, 1 9 8 4 ) .

To date, bombesin has been

reported to produce hypothermia when injected into the
cerebral ventricles (Avery & Calisher, 1982; Babcock,
Barton, & Keene, 1989; Babcock, Barton, Perez, & Hearndon,
1989;

Babcock & Wunder, 1984; Francesconi & Mager, 1981;

Wunder, Hawkins, Avery, & Swan, 1980), the preoptic area
of the hypothalamus (Babcock, Baker, & Moody, 1992;
Babcock & Barton, 1989; Babcock, Barton, Gunion, &
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Rosenthal, 1992; Babcock, Barton, & Keene, 1989; Babcock &
Maisel, 1991; Barton & Babcock, 1990), the hypothalamic
paraventricular nucleus (Babcock & Barton, 1990), and the
substantia nigra (Calisher & Avery, 1984), of animals
tested at normal ambient temperatures.
The prevailing theory is that bombesin-induced
hypothermia in animals tested under normal ambient
temperatures is dependent on some pre-existing condition,
which acts as a "permissive" factor for hypothermia to
occur.

Previous data has established that animals acutely

food-deprived (Avery & Calisher, 1982; Babcock, Baker, &
Moody, 1992; Babcock, Barton, Gunion, & Rosenthal, 1992;
Babcock, Barton, & Keene, 1989; Babcock & Wunder, 1984;
Barton & Babcock, 1990; Calisher & Avery, 1984), injected
with insulin peripherally (Babcock & Barton, 1989; Babcock
& Barton, 1990; Babcock, Barton, Gunion, & Rosenthal,
1992; Babcock, Barton, Perez, & Hearndon, 1989; Barton &
Babcock, 1990), or 2-deoxy-D-glucose (Babcock & Maisel,
1991), or with lesions of the ventromedial hypothalamus
(Barton & Hawkins, 1993), experience hypothermia when
injected with bombesin centrally.

Exactly how these

pre-existing conditions contribute to the production of
bombesin-induced hypothermia at normal ambient
temperatures remains unclear.

It has been theorized that

one potential condition these manipulations may contribute
to is reduced peripheral glucose availability (Babcock &
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Maisel, 1991).

This appears to be supported by findings

that bombesin-induced hypothermia seen in animals acutely
deprived of food or treated with peripheral insulin is
attenuated by allowing the animals to eat (Barton &
Babcock, 1990).
Bombesin-induced hypothermia demonstrated at normal
ambient temperatures is believed to be mediated by
different mechanisms from those seen in conditions of
acute cold exposure.
belief.

Several findings contribute to this

Unlike bombesin-induced hypothermia observed in

cold-exposed animals, hypothermia precipitated by bombesin
at normal ambient temperatures is not attenuated by
peripheral naloxone (Babcock, Barton, & Keene, 1989).
Moreover, hypothermia produced by bombesin at normal
ambient temperatures is not associated with a decrease in
metabolism (Babcock & Wunder, 1984) , yet conflicting data
exists (Lin & Lin, 1986; Shido, Noda, & Nagasaka, 1987;
Tache, Pittman, & Brown, 1980).
The mechanism by which bombesin produces hypothermia
at normal ambient temperatures is unclear.

Lin (Lin &

Lin, 1986), has demonstrated that bombesin-induced
hypothermia under conditions of normal ambient temperature
results in reduced oxygen consumption and increased heat
loss.

In opposition to Lin's data, experiments examining

bombesin-induced heat loss related to hypothermia using
cutaneous tail temperature failed to support this finding
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(Babcock & Barton, 1989).

If bombesin does not alter

metabolic rate, then some form of heat loss must account
for the hypothermia produced.

In support of this theory

are findings that the core body temperature of rats
injected centrally with bombesin drift toward the
temperature of their environment (Tache, Pittman, & Brown,
1980).

Additional support is found in data which

establishes that bombesin produces peripheral vasodilation
(Lin & Lin, 1986).

It has also been shown that bombesin

produces increased evaporative heat loss as measured by
experiments designed to isolate this parameter via direct
calorimetry (Shido, Noda, & Nagasaka, 1987).
Thus, given the previous findings, it is clear that
bombesin can produce hypothermia at normal ambient
temperatures.

Bombesin-induced hypothermia under these

conditions appears to be reliant upon some manipulation of
factors related to nutritional status, which have been
suggested to negatively influence glucose availability.
Reports that bombesin alters resting metabolic rate out
number ones that it does not.

In addition, there is

considerable evidence that bombesin promotes heat loss at
normal ambient temperatures.
The relationship between the permissive events which
contribute to bombesin-induced hypohtermia at normal
ambient temperatures is shown in Figure 2.
food-deprivation or peripheral injection of

Acute
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2-deoxy-D-glucose reduce glucose utilization while having
little affect on glucose availability.

Both peripheral

injection with insulin or lesions of the ventromedial
hypothalamus increase utilization but with differential
affect on availability.

Insulin injection reduces

availability by promoting utilization while lesions of the
ventromedial hypothalamus increases availability as well
as utilization.

Thus, there is no consistent relationship

between the necessary pre-existing events which allow
bombesin-induced hypothermia at normal ambient
temperatures and their affect on glucose utilization or
availability.

Figure 2. Relation of permissive
utilization and availability.
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PROBLEM STATEMENT
Bombesin is known to produce a wide spectrum of
behaviorally and physiologically related effects when
administered centrally.

Previous studies of

bombesin-induced hypothermia have been conducted under
conditions of cold-exposure, food-deprivation, insulin
treatment, 2-deoxy-D-glucose treatment, and lesions of the
ventromedial hypothalamus.

Each of these experimental

manipulations result in hypothermia following central
bombesin administration, yet the underlying mechanisms are
not well understood.

The objective of this study was to

determine if a potential reduction of sympathetic nervous
system stimulation, brought about by the factors
previously shown to be permissive events, is responsible
for bombesin-induced hypothermia at normal ambient
temperatures.
All of the conditions which have been implicated as
permissive factors in bombesin-induced hypothermia produce
reductions in efferent sympathetic nervous system
activation of interscapular brown adipose tissue.
Food-deprivation (Dulloo, Young, & Landsberg, 1988;
Landsberg & Young, 1978; Sakaguchi, Arase, Fisler, & Bray,
1988) and injections of 2-deoxy-D-glucose (Egawa,
Yoshimatsu, & Bray, 1989; Holt & York, 1989; Landsberg &
Krieger, 1989) result in decreased norephinephrine
turnover in brown adipose tissue and reduce firing rates
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of isolated efferent sympathetic nerves that innervate
brown adipose tissue, as do lesions of the ventromedial
hypothalamus (Niijima, Rohner-Jeanrenaud, & Jeanrenaud,
1984).

Additionally, hyperinsulinemic animals also

exhibit reductions in norephinephrine turnover in brown
adipose tissue (Nishioka, Yoshida, Yoshioka, & Kondo,
3.987).

Thus, conditions that permit bombesin-induced

hypothermia in animals tested at normal ambient
temperatures, may do so by attenuating the thermogenic
capacity of brown adipose tissue to compensate for
peripheral heat loss.

This hypothesis receives indirect

support by findings that bombesin-induced hypothermia is
attenuated when animals are allowed to eat (Barton &
Babcock, 1990).

Feeding promotes sympathetic nervous

system activation of brown adipose tissue (Sakaguchi,
Arase, Fisler, & Bray, 1988) and increased heat production
(Himms-Hagen, Hogan, & Zaror-Behrens, 1986; Rothwell &
Stock, 1979; Stock & Rothwell, 1986), as well as its
growth (Sundin & Nechad, 1983) .

Therefore, it seems

plausible that attenuation of bombesin-induced hypothermia
in food-deprived or insulin-treated rats allowed to feed
during testing is mediated by increased thermogenesis in
the brown adipose tissue, secondary to food consumption.
If reduced sympathetic nervous system stimulation of
brown adipose tissue is necessary for bombesin-induced
hypothermia, then ganglionic blockade of the sympathetic
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efferents which innervate brown adipose tissue in rats
administered bombesin, should result in hypothermia at
normal ambient temperatures.

Chlorisondamine administered

peripherally acts on nicotinic receptors within the
sympathetic ganglia to block sympathetic nervous system
activity and prevent increased thermogenesis (Amir,
1990,a; Amir, 1990,b; Amir, 1990,c; Amir & De Blasio,
1991).

In addition, it does not modulate serum glucose

levels or glucose utilization (Turinsky, 1974).
Therefore, ad-libitum fed rats were injected centrally
with bombesin and peripherally with chlorisondamine to
investigate the effect of bombesin on core body
temperature.
If reductions in sympathetic nervous system
stimulation to brown adipose tissue allow bombesin to
produce hypothermia at normal ambient temperatures, then
stimulation of the brown adipose tissue by way of a
sympathomimetic, should block bombesin-induced
hypothermia.'

The experimental compound CL-316,243 is a

drug that acts on P3-adrenergic receptors and has been

demonstrated to promote thermogenesis in brown adipose
tissue (Himms-Hagen et al., 1994).

Chronic treatment of

rats on high fat diets with this compound produces an
increase in metabolic rate, hypertrophy of brown adipose
tissue, and a robust increase in uncoupling protein
(Himms-Hagen et a l ., 1994).

Himms-Hagen (Himms-Hagen et
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a l ., 1994), has theorized that CL-316,243 induces an
increase in total mitochondria in chronic application,
thereby producing the increase in uncoupling protein.
Uncoupling protein promotes oxidation of substrate which
is no longer coupled to adenosine triphosphate synthesis,
thereby providing a unique source of dissipative heat
generation in brown adipose tissues (Klingenberg, 1990).
Thus, peripherally administered CL-316,243 was used to
block the potential effects of

reduced sympathetic

nervous system activation associated with bombesin-induced
hypothermia at normal ambient temperatures.

Hypotheses
The following hypotheses will be addressed under the
proposed experiments:
Hypothesis 1.

If reductions in sympathetic nervous system

activation of brown adipose tissue provide a necessary
pre-existing condition for bombesin-induced hypothermia in
animals tested at normal ambient temperatures, then
ad-libitum fed rats, administered chlorisondamine
peripherally, should become hypothermic after lateral
ventricular injections of bombesin.
Hypothesis 2.

If reduction in sympathetic nervous system

activation of brown adipose tissue thermogenesis acts as
the permissive event for bombesin-induced hypothermia at
normal ambient temperatures, then CL-316,243 administered
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peripherally should prevent bombesin-induced hypothermia
in food-deprived and chlorisondamine treated animals
injected with bombesin into the lateral ventricles.

GENERAL METHODS
Subjects
In all experiments male Sprague-Dawley rats (300-400
g) were used.

Animals were housed individually in

standard wire and steel laboratory cages.

Animals

received ad-libitum access to standard laboratory chow
(Ralston Purina Co.) and water except where mentioned in
specific experimental designs.

Ambient temperatures for

housing and testing procedures was maintained at 24° C (+
2° C ) .

Photopheriod was on a twelve hour schedule with

onset of the dark-phase at 19:00 hrs.

Surgery
A guide cannulae constructed of

22-gauge

stainless-steel tubing was implanted into a lateral
cerebral ventricle of each animal under pentobarbital
anesthesia (35 mg/Kg body weight, i.p.).

After initiation

of anesthesia animals were placed in a stereotaxic
instrument (model 900A, David Kopf Instruments, Tujunga,
CA) and a midline incision made on the superior surface of
the skull.

The skull was trephined and stainless-steel

anchor screws inserted into the bone.

Guide cannulae were

implanted using stereotaxic coordinates 0.9 mm posterior
to bregma, 1.5 mm lateral to midline, and 4.0 mm ventral
to the skull surface (Paxinos & Watson, 1982).
were cemented in place using dental acrylic.
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Cannulae
A 2 6-guage
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wire obturator was kept in the guide cannula to maintain
patency except during injections.

All animals were

provided a 7-10 day post-surgical recovery period prior to
experimentation.
Adrenalectomy was performed under pentobarbital
anesthesia (35 mg/Kg body weight, i.p.).

After initiation

of anesthesia, the surgical area was prepared and
incisions parallel to the spine, caudal to the back
muscles, and immediately posterior to the rib cage were
made.

In the event of complete bilateral adrenalectomy,

exploration and isolation of the adrenals was accomplished
using curved forceps.

The adrenal glands were removed by

blunt dissection and the muscle and skin closed using
interrupted sutures.

In sham adrenalectomized subjects,

the adrenals were visualized and the incisions were
sutured closed.

Following surgery all animals were

allowed a 7-10 day recovery period and were maintained on
sterile 0.9% saline drinking solution in place of tap
water.

Drugs
Anhydrous bombesin (Research Biologicals Inc., CA)
was diluted with 0.9% sterile saline (100 ng/5.0 |il) for
icv administration.

Injections were be made using a

26-guage injector cannula designed to extend 1.0 mm beyond
the ventral aspect of the guide cannula.

The injector
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cannula was connected to a 100 Hi syringe by sterile
polyethylene tubing.

Injection volumes (5.0 |ll) were

infused over a 1 minute period of time using a motor
driven infusion pump (Harvard Apparatus,South Natick, MA) .
Anhydrous chlorisondamine HC1 (CIBA Pharmaceuticals,
Summit, NJ) were diluted with 0.9% sterile saline (2.5
mg/1 ml) for i.p. injection.

Anhydrous CL-316,243

(American Cyanamid, Wayne, NJ) was diluted with 0.9%
sterile saline (1.0 mg/1 ml) for i.p. injection.
Crystalline corticosterone (ICN Biomedicals, Costa Mesa,
CA) was dissolved in polyoxyethylenesorbitan monolaurate
(Tween 20)

(Sigma, St. Louis, MO) and then diluted with

sterile saline in a 1:5 ratio (0.1 mg/ ml).

Peripheral

injections were made using a 1 ml syringe and 26-guage
hypodermic needle.

Cannulae Verification
At the completion of testing, animals were sacrificed
by carbon dioxide euthanasia.

An injector was placed into

the guide cannula and a 5.0 |il volume of India ink
infused.

Brains were removed from craniums and coronal

sections made to examine the ventricles for ink infusion.
Only data coming from those animals having ink infusion
into the lateral cerebral ventricles were used for
analysis.
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Statistics
Data was evaluated using analysis of variance (ANOVA)
using the computer program SigmaStat (Jandel Scientific,
San Rafael, Ca).

Differences between group means were

analyzed using Newman-Keuls post hoc test.

EXPERIMENT I
Introduction
Bombesin-induced hypothermia in animals tested at
normal ambient temperatures appears to require an
antecedent event(s) which has been linked to reduction in
sympathetic stimulation of brown adipose tissue.

The

importance of brown adipose activity in the induction of
bombesin-induced hypothermia is unknown.

This study

evaluated core body temperature using peripheral
chlorisondamine injections to block ganglionic innervation
of the brown adipose tissue prior to central bombesin
administration in ad-libitum fed rats.

Procedure
Beginning at 09:30 animals were removed from their
cages and core body temperatures were measured by
inserting a thermistor probe (Harvard Apparatus, South
Natick, MA) 6.5 cm beyond the anal orifice.

Immediately

after recording temperatures each animal was injected with
either chlorisondamine (2.5 mg/kg) or saline, and returned
to its cage.

Thirty minutes after peripheral injection

the animals were again removed from their cages, core body
temperatures recorded, received central injection of
either bombesin (100 ng/5.0 |il, icv) or saline vehicle
(5.0 }ll), and then returned to their cages.

After 60

minutes had elapsed from central injection, core body
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temperature was recorded to evaluate potential
hypothermia.

A between-group design was utilized

resulting in four groups:

(central/peripheral)

saline/saline, bombesin/saline, bombesin/chlorisondamine,
and saline/chlorisondamine (n=7 per group).

Results
Change in core body temperature defined as the
difference from preinjection levels are shown in Figure 3.
Two-way repeated measures ANOVA demonstrated a significant
effect of treatment condition on core body temperature
[F(3,48)=12.897, p<0.001], as well as a significant effect
of time of recording on core body temperature
[F(2,48)=24.851,

p<0.001].

Additionally, there was a

significant interaction between treatment condition and
time [F(6,48)=20.033, p<0.001].

Newman-Keuls post hoc

testing revealed that body temperature did not differ
significantly between groups as a function of peripheral
injection alone, and that only animals receiving the
combination of central bombesin and peripheral
chlorisondamine became hypothermic.
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Figure 3. Change in core temperature in ad libitum fed
rats treated with bombesin and chlorisondamine. BEFORE,
represents change in core temperature at time of central
injection (30 min post peripheral injection). AFTER,
represents change in core temperature at termination of
experiment (60 min post central injection). Legend
indicates central/peripheral treatment [bombesin (BOM) 100
ng/5n.l, icv; chorisondamine (CHL) 2.5 mg/kg, ip; vehicle
(SAL)]. Bars indicate standard error of the mean.
*p<
0.05 vs SAL/SAL control condition.

EXPERIMENT II
Introduction
Experiment I indicates that bombesin-induced
hypothermia occurs in ad-libitum fed animals treated with
the nicotinic ganglionic receptor blocker,
chlorisondamine.

It is hypothesized that this hypothermia

is secondary to attenuation of sympathetic drive to brown
adipose tissue.

This study examines the hypothesis that

direct activation of thermogenesis in brown adipose
tissue, in animals which have received chlorisondamine,
can attenuate bombesin-induced hypothermia.

This was

accomplished using peripheral injections of the
(33-adrenergic agonist,

CL-316,243.

Procedure
Beginning at 09:30 animals were removed from their
cages and core body temperatures were measured by
inserting a thermistor probe 6.5 cm beyond the anal
orifice.

Immediately after recording temperatures each

animal was injected with either chlorisondamine (2.5
mg/kg) and saline, or chlorisondamine (2.5 mg/kg, ip) and
CL-316,243

(1 mg/kg, ip) and returned to its cage.

Thirty

minutes after peripheral injections the animals were
removed from their cages, core body temperatures recorded,
were administered central injection of either bombesin
(100 ng/5.0 [ll, icv) or saline vehicle (5.0 |ll), and then
65

66

returned to their cages.

After 60 minutes had elapsed

from central injection, the core body temperature was
recorded to evaluate potential hypothermia.

A

between-group design was utilized resulting in four
groups:(central/peripheral) saline/chlorisondamine+saline,
saline/chlorisondamine+CL-316, 243,
bombesin/chlorisondamine+saline, or
bombesin/chlorisondamine+CL-316,243 , (n=7 per group).

Results
Change in core body temperature after treatment with
bombesin and CL-316,243 is shown in Figure 4.

Two-way

repeated measures ANOVA indicated a significant effect of
treatment condition on core body temperature
[F(3,72)=4.05, p<0.01], time of temperature recording on
core body temperature [F(2,72)=8.26, p<0.001], and
interaction between treatment condition and time of
temperature recording [F(6,72)=3.93 , p<0.001].
Newman-Keuls post hoc testing indicates that core body
temperature did not differ between groups as a function of
peripheral injection alone.

The only group that

demonstrated significant hypothermia was the one that
received chlorisondamine + saline peripherally, and
bombesin centrally.

Peripheral injection of CL-316,243

prevented hypothermia in animals receiving central
bombesin following peripheral chlorisondamine treatment.
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Figure 4. Change in core temperature in ad libitum fed
rats following central bombesin and peripheral
chlorisondamine and CL-316,243. BEFORE, represents change
in core temperature at time of central injection (30 min
post peripheral injection). AFTER, represents change in
core temperature at termination of experiment (60 min post
central injection). Inset legend indicates
central/peripheral treatment [bombesin (BOM) 100 ng/5|ll,
icv; chlorisondamine (CHL) 2.5 mg/kg, ip; CL-316,243
(CL)l.O mg/kg; ip; vehicle (SAL)]. Bars indicate standard
error of the mean for each condition and time point.
*p < 0.05 vs SAL/CHL+SAL control condition.

EXPERIMENT III
Introduction
Previous studies have demonstrated that
bombesin-induced hypothermia occurs in acutely
food-deprived animals tested at normal ambient
temperatures (Avery & Calisher, 1982; Babcock, Baker, &
Moody, 1992; Babcock, Barton, Gunion, & Rosenthal, 1992;
Babcock, Barton, & Keene, 1989; Babcock & Wunder, 1984;
Barton & Babcock, 1990; Calisher & Avery, 1984).

Acute

food deprivation is known to result in reduced sympathetic
nervous system drive to brown adipose tissue (Sakaguchi,
Arase, Fisler, & Bray, 1988) but not produce hypoglycemia
(Barton & Babcock, 1990).

Experiment II demonstrated that

the P3-adrenergic sympathomimetic CL-316,243 p r e vents

bombesin-induced hypothermia in ad-libitum fed rats
treated with chlorisondamine, most likely by direct
stimulation of thermogenesis in brown adipose tissue.
This experiment will examine if food-deprivation produces
a permissive event in bombesin-induced hypothermia by
reducing sympathetic stimulation of brown adipose tissue
and if alteration of serum glucose is important in this
event.

If suppression of sympathetic nervous system

activity is the pivotal mechanism in bombesin-induced
hypothermia, then peripheral injections of CL-316,243
should prevent hypothermia under these conditions.
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Procedure
Animals were food-deprived 20 hours prior to central
injections except for a single control group (n=5).
Techniques utilized for recording core body temperature
and animals handling are identical to those detailed in
Experiment I.

Core body temperature was recorded at 3 0

minutes prior to central injection (beginning at 0930), at
the time of central injection,

and 30 and 60 minutes post

central injection.

injections consisted of

Peripheral

either saline, or CL-316,243 (1 mg/Kg, i.p.).

Central

injections consisted of either bombesin (100 ng/5.0 ul,
icv) or saline (5.0 ul).

A between-group design was

utilized resulting in the following drug treatment groups
at specific times:

(condition time relative to central injection) ad

libitum fed_30, food-deprived_30, food-deprived+i .p. saline0,
food-deprived+i .p. CL-316,2430,

icv saline+i.p. saline30,

icv saline+i.p. CL-316,24330, icv bombesin+i .p . saline30,
icv bombesin+i .p.CL-316,24330, icv saline+i.p. saline60, icv
saline+i.p. CL-316,24360, icv bombesin+i .p . saline60, icv
bombesin+i.p. CL-316 ,24360.
animals (n=5 per group).

This resulted

This

in 12 groups of

design can be seen in

Table 1.
Blood samples were collected by decapitation of live
animals and draining trunk blood into sterile test tubes
in an ice chilled container.

The blood was centrifuged at

3500 rpm for 5 minutes using a TRIAC centrifuge, model
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Table 1:

- 3 0 min

Matrix of Test Conditions; Experiment III

0 min

+ 30 min

+ 60 min

BOM/CL

BOM/CL

SAL/CL

SAL/CL

BOM/SAL

BOM/SAL

SAL/SAL

SAL/SAL

CON
CON
SAL/CL
SAL/SAL

Matrix of test conditions. Rows represent treatment
conditions (central/peripheral). Lower 4 rows represent
food-deprivation (20 hr) prior to testing. Columns
represent time of data collection relative to central
injection. Group data from subjects prior to central or
peripheral injection(CON) depicted in far left column. Each
cell represents an experimental group (n = 5/group).
Groups experienced temperature data collection for all time
points to the left of, and including the column of listing.
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number 0200 (Clay Adams, Parsippany, NJ).

The supernatant

was collected and stored at -70° C until assay.

Glucose

assays were performed using the Beckman CX5 UV-hexokinase
method in the Clinical Research Laboratory, Pennington
Biomedical Research Center, Baton Rouge, LA.

Results
Change in core body temperature secondary to
treatment condition and time are shown in Table 2.
Analysis of variance indicate that there is a significant
effect of treatment condition on core body temperature
[F(ll,48)=21.8, p< 0.0001].

Newman-Keuls post hoc testing

demonstrated that only the group which received bombesin
centrally and saline peripherally became hypothermic, that
they were more hypothermic at 60 minutes after central
injection than at 30 minutes, and that peripheral
injection with CL-316,243 prevented bombesin-induced
hypothermia at both time points.

Additionally, a two-way

repeated measures ANOVA performed on the four groups which
progressed through all temperature measurement points
demonstrated a significant effect of, treatment condition
on core body temperature [F(3,48)=18.3 , p<0.0001], as well
as on time of recording [F(3,48)=34.3, p<0.0001], and
interaction between treatment condition and time or
recording [F(9 ,48)=20.8, p<0.0001].

The change in core

temperature in these groups can be seen in Figure 5.
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Table 2: Core Body Temperature for Treatment Groups
Relative to Injection Time and Condition.

Condition

- 30 min

+ 30 min

+ 60 min

37.8±0.27

37.9±0.213

FD SAL/CL

3 8 .1±0.178

38.0±0.124

FD BOM/CL

37.8+0.279

38.1±0.233

FD BOM/SAL

*36.1+0.275

**34.5+0.499

CON

38.2±0.139

FD CON

38.4±0.121

0 min

FD -/S A L

38.2+0.164

FD - /CL

38.0±0.226

FD SAL/SAL

Lower 7 rows (FD) represents food-deprivation (20 hr) prior
to testing. Treatment conditions (central/peripheral):
SAL= saline, BOM = bombesin, CL = CL-316,243, CON = groups
which received no injections. Each cell represents an
experimental group (n = 5/group) (°C+SEM) . *p<0.05 from all
other conditions.
**p<0.05 from BOM/SAL condition at 30
mi n .
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Data from glucose analysis can be seen in Table 3.
One-way ANOVA on glucose data revealed that there was a
significant effect of sample condition on glucose levels
[F(ll,48)=13.798, pcO.OOl].

Newman-Keuls post hoc testing

revealed that groups receiving saline centrally and
CL-316,243 peripherally had significantly lower serum
glucose levels than all other groups.

Rats which were

acutely deprived of food had glucose levels no different
from animals allowed ad libitum access to food.
Additionally, central injection of bombesin prevented the
reduction of serum glucose levels seen in animals treated
with CL-316,243 peripherally.
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Figure 5. Change in core temperature in acutely fasted
rats following central bombesin and peripheral CL-316,243.
Abscissa categories indicate change in temperature
collection relative to time of central injection (0, 30, 60
min). Inset legend indicates central/peripheral treatment
[bombesin (BOM) 100 ng/5 |il, icv; CL-316,243 (CL) 1 mg/kg,
ip; vehicle (SAL)]. Bars indicate standard error of the
mean for each condition and time point.
*p< 0.05 vs SAL/SAL control condition.
**p< 0.05 vs BOM/SAL condition at 30 min.
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Table 3: Mean Serum Glucose Levels for Treatment Groups
Relative to Injection Time and Condition.

Condition

- 30 min

ad-lib fed

142.2±3.02

food-deprived

151.0±2.7

FD SAL/CL
FD SAL/SAL
FD BOM/SAL
FD BOM/CL

0 min

+ 30 min

+ 60 min

* 60.8±1.94

* 72.6±5.1

* 79.0±2.39

130±3.99

121.2±2.96

112.4±1.33

141.4±10.5

150.2±16.8

122.0±13.62

109.6±12.7

Serum glucose levels (mg/DL + SEM) for treatment conditions
at time points relative to central injection (columns).
Treatment conditions (central/peripheral): SAL = saline,
BOM = bombesin, CL = CL-316,243. Prefix FD represent data
from rats food-deprived (20 hr) prior to treatment
conditions.
*p<0.05 from ad-lib fed controls.

EXPERIMENT IV
Introduction
The sympathetic nervous system can modulate serum
glucose

levels by neural innervation of the adrenal

medulla

(Clutter, Rizza, Gerich, & Cryer, 1988) .

Hypothalamic stimulation of the sympathetic nervous system
causes the production and release of epinephrine, which in
turn causes release of glucose from the liver (Guyton,
1991).

Stress is known to increase the release of

corticosterone in rats (Mormede et a l ., 1990) and
elevations in corticosterone levels are known to suppress
sympathetic nervous system activation of brown adipose
tissue (Davidovic, Vasilev, & Stojanovic-Susulic, 1992).
In addition, central bombesin administration produces
hyperglycemia secondary to stimulation of release of
epinephrine from the adrenal medulla (Brown, Tache, &
Fisher, 197 9).

Previous experiments have demonstrated

that adrenalectomized animals become hypothermic after
central bombesin under conditions of food-deprivation
(Barton, unpublished) but, confirmation of adrenalectomy
was not performed.

Thus, the contribution of adrenal

products, specifically epinephrine, on bombesin-induced
hypothermia at normal ambient temperatures is unknown.
This study will examine the impact of bombesin in
adrenalectomized rats.
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Procedure
Animals were food-deprived 20 hours prior to central
injections.

Adrenalectomized animals received

corticosterone replacement (0.1 mg/kg, s.q.)

(Tempel,

McEwen, & Leibowitz, 1992) while sham adrenalectomized
animals received vehicle injections (1.0 ml/kg, s.q.) at
0500 each day after peripheral surgery.

All animals were

maintained on saline drinking solution.

Techniques

utilized for recording core body temperature and animals
handling are identical to those detailed in Experiment I.
Core body temperature was recorded at the time of central
injection and 60 minutes post central injection.

This

resulted in a between-subjects design with three
experimental groups tested under the following conditions:
(surgical treatment+central injection/peripheral
injection) sham adrenalectomy+vehicle/vehicle,
sham adrenalectomy+bombesin/vehicle, and
adrenalectomy+bombesin/corticosterone (n=7 per group).
Immediately following the last data collection period
animals were sacrificed and trunk blood collected in ice
chilled test tubes.

Serum was collected and stored as

described in Experiment III.

Confirmation of complete

adrenalectomy was established by serum aldosterone assay.
Aldosterone assays were performed using Aldosterone-MAIA
in vitro radioimmunoassay diagnostic kits (CIBA-Corning
Diagnostics Corp., East Walpole, MA), in the Clinical
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Research Laboratory, Pennington Biomedical Research
Center, Baton Rouge, LA.

The criterion for complete

adrenalectomy was serum aldosterone levels below 5 pg/ml.

Results
Figure 6 depicts changes in core body temperature
after bombesin treatment in food-deprived rats with and
without adrenalectomy.

Analysis of data using two-way,

repeated measures ANOVA demonstrated a significant effect
for treatment condition [F(2,18)=26.9, p<0.0001], time of
recording [F(l,18)=161.9, p<0.0001], and interaction
between the two [F(2,18)=88.8, p<0.0001].

Newman-Keuls

post hoc testing revealed that food-deprived animals
became hypothermic 60 minutes after central bombesin
injection with or without adrenalectomy, and that
adrenalectomized animals were significantly more
hypothermic than sham adrenalectomized animals after
bombesin treatment.
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Figure 6. Change in core body temperature in acutely
fasted rats following central bombesin with and without
adrenalectomy.
Inset legend indicates peripheral surgical
treatment + central injection/peripheral injection [sham
adrenalectomy (SADX); adrenalectomy (ADX); bombesin (BOM)
100 ng/ 5(il, icv; corticosterone (CORT) 0.1 mg/kg, sc;
vehicle (VEH)]. Bars indicate standard error of the mean.
* p< 0.05 vs SADX+VEH/VEH control condition.
** p< 0.05 vs
SADX+BOM/VEH condition.

DISCUSSION
The four experiments conducted in this dissertation
provide robust evidence that bombesin produces hypothermia
in rats tested at normal ambient temperatures under
conditions in which the normal reflex sympathetic
activation of brown adipose tissue thermogenesis is
blunted.

In Experiment I, it was proven that

bombesin-induced hypothermia could be produced under
conditions of ad-libitum access to food by using the
ganglionic blocker chlorisondamine.

Chlorisondamine is

known to act peripherally to prevent activation of brown
adipose tissue thermogenesis by suppressing sympathetic
drive (Amir, 1990,a; Amir, 1990,b; Amir, 1990,c; Amir & De
Blasio, 1991).

Additionally, chlorisondamine does not

effect serum glucose levels or glucose utilization
(Turinsky, 1974).

Data from Experiment II demonstrates

that bombesin produces hypothermia when administered
centrally to ad-libitum fed rats treated peripherally with
chlorisondamine, as in Experiment I, and that this
hypothermia is prevented by addition of peripheral
treatment with the P3-receptor agonist, CL-316,243.

The

sympathomimetic, CL-316,243 is known to act selectively on
P3-adrenergic receptors (Bloom et al., 1992) which are
found primarily in adipose tissues, and produce
thermogenic responses when activated (Himms-Hagen et a l .,
1994).

In Experiment III, central bombesin injection
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produced hypothermia in acutely food-deprived rats tested
at normal ambient temperatures, confirming previous
reports (Avery & Calisher, 1982; Babcock, Baker, & Moody,
1992; Babcock, Barton, Gunion, & Rosenthal, 1992; Babcock,
Barton, & Keene, 1989; Babcock & Wunder, 1984; Barton &
Babcock, 1990; Calisher & Avery, 1984), and this
hypothermia was prevented by peripheral treatment with
CL-316,243.

In addition, serum glucose data from

Experiment III establishes that peripheral treatment with
CL-316,243 produces hypoglycemia relative to food-deprived
animals receiving saline control treatment or ad-libitum
fed rats, and that central bombesin attenuates this
hypoglycemia.

Experiment IV demonstrated that bombesin

produces hypothermia in acutely food-deprived
adrenalectomized rats with corticosterone replacement, and
in sham adrenalectomized rats.

Furthermore, after central

bombesin treatment adrenalectomized rats with
corticosterone replacement became significantly more
hypothermic than sham adrenalectomized rats.

This

implicates adrenal catecholamines, and possibly
corticotrophin-releasing hormone, in modulation of this
phenomenon.
Previous reports of bombesin-induced hypothermia at
normal ambient temperatures have been associated with some
type of pre-existing condition, which had to be present
for hypothermia to be expressed.

Early work by Avery
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(Avery & Calisher, 1982), discovered bombesin-induced
hypothermia in food-deprived rats tested at normal ambient
temperatures incidentally, as it was not the main
objective of their study.

They hypothesized that bombesin

may produce hypothermia in food-deprived rats secondary to
a change in nutritional state, possibly due to a depletion
of metabolic fuels (Avery & Calisher, 1982).

This

hypothesis appeared to spawn increased interest in altered
nutritional conditions which might contribute to
bombesin-induced hypothermia at normal ambient
temperatures.

Examination of possible metabolic

suppression by bombesin revealed that in food-deprived
rats there is no change in oxygen consumption associated
with development of hypothermia at normal ambient
temperatures (Babcock & Wunder, 1984).

Babcock (Babcock &

Barton, 1989; Babcock & Barton, 1990; Babcock, Barton,
Gunion, & Rosenthal, 1992; Babcock, Barton, & Keene, 1989;
Babcock, Barton, Perez, & Hearndon, 1989; Barton &
Babcock, 1990), demonstrated that bombesin produces
hypothermia in ad-libitum fed rats tested at normal
ambient temperatures if first injected peripherally with
insulin.

He believed that peripheral injections of

insulin simulated the fasted state by producing
hypoglycemia and stimulating feeding.

Later reports

showed that bombesin-induced hypothermia could be
exhibited in ad-libitum fed rats if first treated with

83

peripheral 2-deoxy-D-glucose (Babcock & Maisel, 1991) or
if they had lesions of the ventromedial hypothalamus
(Barton & Hawkins, 1993).

Babcock has suggested that

bombesin-induced hypothermia in ad-libitum fed animals
treated with 2-deoxy-D-glucose may be secondary to a
reduction of glucose utilization (Babcock & Maisel, 1991),
or in the case of insulin treatment, glucose availability
(Babcock & Barton, 1990).

Superficially, this appears to

be supported by findings that allowing animals to eat
during testing attenuated bombesin-induced hypothermia
(Barton & Babcock, 1990).

Furthermore, examination of

serum metabolic fuels seemed to reinforce this concept, as
that serum glucose levels declined secondary to insulin
treatment in ad-libitum fed rats made hypothermic with
bombesin (Babcock, Barton, Gunion, & Rosenthal, 1992).
While the idea that reduced glucose availability or
utilization may act in some way to allow bombesin to
produce hypothermia, it seems inadequate in providing any
concrete mechanism by which it would produce this event.
York and Bray (personal communication ), upon reviewing the
findings of reports on bombesin-induced hypothermia at
normal ambient temperatures, suggested an alternative
mechanism through which the permissive events might
influence this phenomenon.

Their observation was, that

all conditions which contribute to bombesin-induced
hypothermia at normal ambient temperatures are also
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associated with reduced sympathetic nervous system
activation of thermogenesis.

This observation became the

nucleus for the development of the hypothesis that
bombesin-induced hypothermia in animals tested at normal
ambient temperatures is dependent upon a pre-existing
state of suppressed sympathetic nervous system drive to
brown adipose tissue.

Previous studies provide

significant support for this supposition.

Acute

starvation which permits bombesin-induced hypothermia
(Babcock, Baker, & Moody, 1992; Babcock & Wunder, 1984;
Calisher & Avery, 1984), also results in decreased
norephinephrine turnover in brown adipose tissue (Dulloo,
Young, & Landsberg, 1988; Landsberg & Young, 1978) as well
as reductions in sympathetic nervous system drive
(Sakaguchi, Arase, Fisler, & Bray, 1988).

Treatment with

2-deoxy-D-glucose that allow bombesin-induced hypothermia
(Babcock & Maisel, 1991), are also known to suppress
sympathetic nervous system activity (Egawa, Yoshimatsu, &
Bray, 1989; Landsberg & Krieger, 1989).

Ad-libitum fed

animals made hyperinsulinemic will become hypothermic
following central bombesin (Babcock & Barton, 1989;
Babcock & Barton, 1990; Babcock, Barton, Gunion, &
Rosenthal, 1992; Barton & Babcock, 1990; Babcock, Barton,
Perez, & Hearndon, 1989), and hyperinsulinemia also
suppresses norephinephrine turnover in brown adipose
tissue (Nishioka, Yoshida, Yoshioka, & Kondo, 1987).
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Lesions of the ventromedial hypothalamus not only allow
bombesin-induced hypothermia in ad-libitum fed rats
(Barton & Hawkins, 1993), but are also known to suppress
sympathetic efferent firing rates of nerves which
innervate brown adipose tissue (Niijima,
Rohner-Jeanrenaud, & Jeanrenaud, 1984).

Furthermore, the

act of feeding which attenuates bombesin-induced
hypothermia (Barton & Babcock, 1990), also promotes heat
production (Himms-Hagen, Hogan, & Zaror-Behrens, 1986;
Rothwell & Stock, 1979; Stock & Rothwell, 1986) and
increases firing rates of sympathetic nerves innervating
brown adipose tissue (Sakaguchi, Arase, Fisler, & Bray,
1988).

Thus, all conditions which promote

bombesin-induced hypothermia are directly linked to
suppression of sympathetic nervous system activation of
thermogenesis.

Additionally, those which attenuate

bombesin-induced hypothermia are also linked to increased
sympathetic nervous system activation of thermogenesis.
The potential

modulatory effects on glucose

utilization by adrenal catecholamines in bombesin-induced
hypothermia is addressed by findings from Experiment IV.
It is known that elevated adrenal epinephrine release
limits glucose utilization by activation of a and
P-adrenergic receptors (Cryer, 1992).

Epinephrine

activation of a-adrenergic receptors results in inhibition
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of insulin release and promotes hyperglycemia (Clutter,
Rizza, Gerich, & Cryer, 1988) .

In addition, activation of

p-adrenergic receptors by epinephrine adds a synergism to
this phenomenon by stimulating glucagon secretion, hepatic
glycogenolysis, and gluconeogenesis (Skikama & Ui, 1975).
Bombesin itself, produces marked increases in epinephrine
after central administration (Brown, Carver & Fisher,
1988; Brown & Fisher, 1984).

In addition, bombesin is

known to produce hyperglucagonemia and hypoinsulinemia
(Brown, Tache, & Fisher, 1979).

Hyperglycemia following

icv bombesin injection is eliminated by adrenalectomy,
suggesting that bombesin acts through neural activation of
the adrenals to produce this event.

Given the data from

Experiment IV, as well as these other findings, it appears
that decreased glucose utilization is inadequate as an
explanation for bombesin-induced hypothermia, especially
in light of the fact that bombesin itself generates
changes conducive to reduced glucose utilization.

This is

supported by findings that bombesin-induced hypothermia
occurs in ad-libitum fed animals after peripheral
injections of insulin, since insulin actually promotes
increased glucose utilization (Cryer, 1992).
The data collected from the four experiments detailed
here, along with previous findings provide overwhelming
evidence that bombesin-induced hypothermia is mediated by
sympathetic nervous system activity.

This hypothesis is
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efficaciously depicted in Figure 7.

Bombesin acts on

central sites, most likely the preoptic area, to stimulate
peripheral vasodilation which results in heat loss.

Under

normal food-sated conditions, this does not result in
hypothermia because of reflex activation of thermogenesis
by the sympathetic nervous system.

When animals are under

conditions of acute starvation, peripheral injection of
insulin or 2-deoxy-D-glucose, or have lesions of the
ventromedial hypothalamus, the reflex sympathetic
activation of

thermogenesis is prevented at the level of

the central nervous system, and hypothermia results.

In

bombesin-induced hypothermia in ad-libitum fed rats
injected peripherally with chlorisondamine, the blockade
of sympathetic activation of thermogenesis occurs at the
level of the peripheral ganglia.

When bombesin-induced

hypothermia seen in food-deprived or
chlorisondamine-treated rats is prevented by peripheral
injection with CL-316,243, thermogenesis is restored
secondary to direct stimulation of the P3-adrenergic

receptor in the brown adipose tissue.
Bombesin may have developed as an evolutionary
process in homeotherms acting as an integrative mechanism
to dissipate increased heat secondary to feeding related
thermogenesis, and act as a satiety agent.

The act of
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Figure 7. Hypothesis that bombesin-induced hypothermia is
dependant on suppression of sympathetic nervous system
activity.

nutrient ingestion induces sympathetic nervous system
activation of thermogenesis via activation of the brown
adipose tissues (Himms-Hagen, Hogan, & Zaror-Behrens,
1986; Rothwell & Stock, 1979; Sakaguchi, Arase, Fisler, &
Bray, 1988; Stock & Rothwell, 1986).

It is known that

ingestion of food stimulates release of the mammalian
counterpart to bombesin, gastrin-releasing peptide, both
in the periphery, and in the central nervous system (Kateb
& Merali, 1992).

Thus, it is possible that as a mammal

consumes food, the gastrin-releasing peptide levels
increase as does production.

This may result in increased

vasodilation and heat loss as a compensatory mechanism to
thermogenesis.

At the same time, it acts as a negative

feedback signal to the actual consumption of food.

In

this event, hypothermia would not occur since sympathetic
activation of thermogenesis is probably more than adequate
to offset the heat loss caused by peripheral vasodilation.
A simplistic pictorial representation of this theory can
be seen in Figure 8.
Conclusions
1.

Bombesin-induced hypothermia at normal ambient

temperatures is dependent upon a pre-existing state of
attenuated sympathetic nervous system activation of
compensatory thermogenesis.
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Figure 8. Theory of bombesin as an integrative peptide in
coregulation of temperature and feeding.

2.

Bombesin-induced hypothermia seen at normal ambient

temperatures is not directly related to serum glucose
levels associated with the fasted state alone.
3.

Peripheral activation of thermogenesis, specifically

in brown adipose tissue, prevents bombesin-induced
hypothermia at normal ambient temperatures by restoring
compensatory heat production.
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